School of Medicine Homepage
Emory University Shield
  • About
    • Our Vision
    • Academic Departments
    • Our Leadership
    • Health Care Partnerships
    • Diversity, Equity, & Inclusion
    • Location
    • Supporting Our People
    • Our Faculty
    • History
    • News
    • Events
    • Contact Us
  • Education
    • Degree and Certificate Programs
    • Academic Departments
    • Residents & Fellows
    • Postdoctoral Training
    • Continuing Medical Education
    • Admissions
    • Cost and Financial Aid
    • Student Resources
  • Research
    • Research Innovation
    • Conducting Research
    • Core Facilities
    • Research Centers
    • Research Training
    • Academic Departments
    • Find a Researcher
    • Research News
  • Clinical Experience
    • Where We Work
    • Caring for a Diverse Population
    • Faculty Clinical Experience
    • Advanced Patient Care
    • Academic Departments
    • Community Learning
  • Giving
  • Directory

Directory section navigation

  • Faculty Profiles

Emory University School of Medicine

  • About
    • Sub link
      Our Vision
    • Sub link
      Academic Departments
    • Sub link
      Our Leadership
    • Sub link
      Health Care Partnerships
    • Sub link
      Diversity, Equity, & Inclusion
    • Sub link
      Location
    • Sub link
      Supporting Our People
    • Sub link
      Our Faculty
    • Sub link
      History
    • Sub link
      News
    • Sub link
      Events
    • Sub link
      Contact Us
  • Education
    • Sub link
      Degree and Certificate Programs
    • Sub link
      Academic Departments
    • Sub link
      Residents & Fellows
    • Sub link
      Postdoctoral Training
    • Sub link
      Continuing Medical Education
    • Sub link
      Admissions
    • Sub link
      Cost and Financial Aid
    • Sub link
      Student Resources
  • Research
    • Sub link
      Research Innovation
    • Sub link
      Conducting Research
    • Sub link
      Core Facilities
    • Sub link
      Research Centers
    • Sub link
      Research Training
    • Sub link
      Academic Departments
    • Sub link
      Find a Researcher
    • Sub link
      Research News
  • Clinical Experience
    • Sub link
      Where We Work
    • Sub link
      Caring for a Diverse Population
    • Sub link
      Faculty Clinical Experience
    • Sub link
      Advanced Patient Care
    • Sub link
      Academic Departments
    • Sub link
      Community Learning
  • Giving
  • Directory
  • Home School of Medicine Home
  • Directory

Profile

Andrew Miller MD

  • Department of Psychiatry and Behavioral Sciences
    Professor
  • (404) 727-8260
  • amill02@emory.edu
  • Emory Behavioral Immunology Program Twitter Feed
  • Emory Behavioral Immunology Program
Head shot of Andrew Miller

Overview

Dr. Andrew H. Miller is William P. Timmie Professor and Vice Chair for Research in the Department of Psychiatry and Behavioral Sciences at the Emory University School of Medicine in Atlanta, Georgia. He is an internationally recognized expert in interactions between the brain and immune system as they relate to depression. His work has demonstrated that during immune activation, inflammatory cytokines can access the brain and interact with the metabolism of dopamine and glutamate, while altering neurocircuits relevant to motivation and reward as well as anxiety and alarm. Additionally, Dr. Miller and his group conducted the first clinical trial examining the efficacy of an immunotherapy (cytokine antagonist) for the treatment of depression. He has produced over 300 scholarly publications, won numerous research, teaching and mentoring awards, is an ISI highly cited researcher and is a Board-Certified Psychiatrist. He has also been nominated as a "Top Doctor" in Psychiatry for the past 3 years.

Academic Appointment

  • Professor, Department of Hematology and Oncology, Winship Cancer Institute, Emory University School of Medicine
  • William P. Timmie Professor of Psychiatry and Behavioral Sciences, Emory University School of Medicine
  • Scientific Affiliate, Emory University School of Medicine Psychoanalytic Institute, Emory University School of Medicine
  • Professor, Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine
  • Neuroscience Faculty Member, Graduate Division of Biological and Biomedical Sciences, Emory University
  • Head, Laboratory of Neuroendocrine-Immune Interactions, Emory University School of Medicine

Education

Degrees

  • MD from Medical College of Georgia
  • BA from Hamilton College

Research

Focus

  • Dr. Miller's work focuses on the impact of the activated immune system on behavior and health. He is also interested on the role of glucocorticoid hormones and their receptors in the regulation of inflammatory responses.

Publications

  • Inflammation is associated with avolition and reduced resting state functional connectivity in corticostriatal reward circuitry in patients with schizophrenia.
    Neuropsychopharmacology
    04/24/2025 Authors: Goldsmith DR; Ning CS; Strauss GP; Gross RE; Cooper JA; Wommack EC; Haroon E; Felger JC; Walker EF; Treadway MT
  • Not All Neuroinflammation Is Created Equal: The Dual Nature of Astrogliosis.
    Biol Psychiatry Volume: 97 Page(s): 758 - 760
    04/15/2025 Authors: Haroon E; Felger JC; Miller AH
  • Designing Clinical Trials for an Inflammatory Subtype of Major Depressive Disorder.
    Biol Psychiatry
    04/10/2025 Authors: Miller AH; Felger JC; Haroon E
  • A randomized proof-of-mechanism trial of TNF antagonism for motivational deficits and related corticostriatal circuitry in depressed patients with high inflammation.
    Mol Psychiatry Volume: 30 Page(s): 1407 - 1417
    04/01/2025 Authors: Treadway MT; Etuk SM; Cooper JA; Hossein S; Hahn E; Betters SA; Liu S; Arulpragasam AR; DeVries BAM; Irfan N
  • Advancing precision psychiatry and targeted treatments: Insights from immunopsychiatry.
    Brain Behav Immun Volume: 125 Page(s): 319 - 329
    03/01/2025 Authors: Miller AH; Berk M; Bloch G; Briquet-Laugier V; Brouillon C; Cuthbert BN; Dantzer R; Davis MC; De Picker LJ; Drevets WC
  • Sustained effects of repeated levodopa (L-DOPA) administration on reward circuitry, effort-based motivation, and anhedonia in depressed patients with higher inflammation.
    Brain Behav Immun Volume: 125 Page(s): 240 - 248
    03/01/2025 Authors: Bekhbat M; Li Z; Dunlop BW; Treadway MT; Mehta ND; Revill KP; Lucido MJ; Hong C; Ashchi A; Wommack EC
  • Longitudinal Fatigue Symptoms and Inflammatory Markers in African American Adults With Hypertension and Obstructive Sleep Apnea.
    Nurs Res Volume: 74 Page(s): 9 - 19
    01/01/2025 Authors: Giordano NA; Houser MC; Pelkmans J; Pasquel FJ; Pak V; Rogers AE; Yeager KA; Mucha S; Schmitt M; Miller AH
  • DNA methylation profiles of cancer-related fatigue associated with markers of inflammation and immunometabolism.
    Mol Psychiatry Volume: 30 Page(s): 76 - 83
    01/01/2025 Authors: Xiao C; Peng G; Conneely KN; Zhao H; Felger JC; Wommack EC; Higgins KA; Shin DM; Saba NF; Bruner DW
  • Psychometric Assessment of Anxiety Measures in a Pilot Study of African American Patients with Obstructive Sleep Apnea.
    Clin Nurs Res Volume: 33 Page(s): 603 - 609
    11/01/2024 Authors: Brock L-U; Yeager KA; Miller AH; Pelkmans J; Graetz I; Giordano NA
  • Rewiring the brain: Inflammation's impact on glutamate and neural networks in depression.
    Neuropsychopharmacology Volume: 50 Page(s): 312 - 313
    11/01/2024 Authors: Haroon E; Miller AH
  • Recruitment and Retention Issues in a Technology-Based Intervention Among Korean American Midlife Women With Depressive Symptoms.
    Comput Inform Nurs Volume: 42 Page(s): 648 - 654
    09/01/2024 Authors: Im E-O; Chee W; Kim SY; Dunbar S; Miller AH; Paul S; Lee M; Jung W
  • A randomized proof-of-mechanism trial of TNF antagonism for motivational anhedonia and related corticostriatal circuitry in depressed patients with high inflammation.

    03/05/2024 Authors: Treadway M; Etuk S; Cooper J; Hossein S; Hahn E; Betters S; Liu S; Arulpragasam A; DeVries B; Irfan N
  • Associations of differentially expressed genes with psychoneurological symptoms in patients with head and neck cancer: A longitudinal study.
    J Psychosom Res Volume: 175 Page(s): 111518
    12/01/2023 Authors: Lin Y; Peng G; Bruner DW; Miller AH; Saba NF; Higgins KA; Shin DM; Claussen H; Johnston HR; Houser MC
  • Simultaneous separation and detection of nine kynurenine pathway metabolites by reversed-phase liquid chromatography-mass spectrometry: Quantitation of inflammation in human cerebrospinal fluid and plasma.
    Anal Chim Acta Volume: 1278 Page(s): 341659
    10/16/2023 Authors: Patel VD; Shamsi SA; Miller A; Liu A; Powell M
  • Circulating short chain fatty acids and fatigue in patients with head and neck cancer: A longitudinal prospective study.
    Brain Behav Immun Volume: 113 Page(s): 432 - 443
    10/01/2023 Authors: Xiao C; Fedirko V; Claussen H; Richard Johnston H; Peng G; Paul S; Maner-Smith KM; Higgins KA; Shin DM; Saba NF
  • Beyond the symptom: the biology of fatigue.
    Sleep Volume: 46
    09/08/2023 Authors: Raizen DM; Mullington J; Anaclet C; Clarke G; Critchley H; Dantzer R; Davis R; Drew KL; Fessel J; Fuller PM
  • Performance of PROMIS Measures to Assess Fatigue and Sleep Symptom Severity Among African American Patients Newly Diagnosed With Obstructive Sleep Apnea.
    Clin Nurs Res Volume: 32 Page(s): 1041 - 1045
    09/01/2023 Authors: Giordano NA; Pasquel FJ; Pak V; Rogers AE; Selimovic S; Pelkmans J; Miller AH
  • Psychedelics and ketamine are a symptom of psychiatry's woes, not a cure.
    Mol Psychiatry Volume: 28 Page(s): 3167 - 3168
    08/01/2023 Authors: Miller AH; Raison CL
  • Longitudinal associations among physical activity, inflammatory markers, and quality of life in patients with head and neck cancer.
    Head Neck Volume: 45 Page(s): 1952 - 1966
    08/01/2023 Authors: Huang S; Zhan Y; Jeon S; Bruner DW; Miller AH; Felger JC; Wommack EC; Saba NF; Higgins KA; Irwin ML
  • Cerebrospinal fluid levels of 5-HIAA and dopamine in people with HIV and depression.
    J Neurovirol Volume: 29 Page(s): 440 - 448
    08/01/2023 Authors: Fu R; Jinnah H; Mckay JL; Miller AH; Felger JC; Farber EW; Sharma S; Whicker N; Moore RC; Franklin D
  • Associations of inflammation with neuropsychological symptom cluster in patients with Head and neck cancer: A longitudinal study.
    Brain Behav Immun Health Volume: 30 Page(s): 100649
    07/01/2023 Authors: Amirkhanzadeh Barandouzi Z; Bruner DW; Miller AH; Paul S; Felger JC; Wommack EC; Higgins KA; Shin DM; Saba NF; Xiao C
  • Unsupervised Hierarchical Clustering of Head and Neck Cancer Patients by Pre-Treatment Plasma Metabolomics Creates Prognostic Metabolic Subtypes.
    Cancers (Basel) Volume: 15
    06/14/2023 Authors: Eldridge RC; Qin ZS; Saba NF; Houser MC; Hayes DN; Miller AH; Bruner DW; Jones DP; Xiao C
  • Guilt by Association: Inflammation and Shared Genetic Risk Between Stress-Related and Immune Disorders.
    Am J Psychiatry Volume: 180 Page(s): 259 - 261
    04/01/2023 Authors: Miller AH; Binder EB
  • Outcomes Stratification of Head and Neck Cancer Using Pre- and Post-treatment DNA Methylation From Peripheral Blood.
    Int J Radiat Oncol Biol Phys Volume: 115 Page(s): 1217 - 1228
    04/01/2023 Authors: Qian DC; Ulrich BC; Peng G; Zhao H; Conneely KN; Miller AH; Bruner DW; Eldridge RC; Wommack EC; Higgins KA
  • Quantitation of tryptophan and kynurenine in human plasma using 4-vinylphenylboronic acid column by capillary electrochromatography coupled with mass spectrometry.
    Electrophoresis Volume: 44 Page(s): 529 - 539
    03/01/2023 Authors: Patel VD; Shamsi SA; Miller A; Liu A
  • New and emerging approaches to treat psychiatric disorders.
    Nat Med Volume: 29 Page(s): 317 - 333
    02/01/2023 Authors: Scangos KW; State MW; Miller AH; Baker JT; Williams LM
  • Burning down the house: reinventing drug discovery in psychiatry for the development of targeted therapies.
    Mol Psychiatry Volume: 28 Page(s): 68 - 75
    01/01/2023 Authors: Miller AH; Raison CL
  • Interleukin-6 Decreases Dopamine Availability and Gene Pathways Related to Vesicular Transport and Release in Human Pluripotent Stem Cell Derived Dopaminergic Neurons
    Volume: 47 Page(s): 188 - 188
    12/01/2022 Authors: Miller A; Lucido M; Xu CC; Huang Y; Niu W; Wen Z
  • Immunometabolic Gene Pathways are Associated With Anhedonia and Altered Following a TNF-Alpha Antagonist in Patients With Depression and High Inflammation
    Volume: 47 Page(s): 232 - 232
    12/01/2022 Authors: Bekhbat M; Haroon E; Etuk S; Felger J; Miller A; Treadway M
  • From Blue to Gray: Inflammation, Aging and Neurodegeneration in Depression
    Volume: 47 Page(s): 246 - 247
    12/01/2022 Authors: Haroon E; Beltran D; Chen X; Wommack E; Roberts B; Qiu D; Goldstein F; Treadway M; Felger J; Miller A
  • RETROSPECTIVE REVIEW OF GLIOMA PATIENTS WITH CONFIRMED MET AMPLIFICATION OR FUSION
    Volume: 24 Page(s): 39 - 39
    11/01/2022 Authors: Tadipatri R; Ekhator C; Miller A; Grewal J; Ahluwalia M; Fonkem E
  • Reappraisal of MS cognition in the modern treatment and diagnostic Era: impaired memory despite normal processing speed refutes the entrenched speed-centric framework
    Volume: 28 Page(s): 118 - 119
    10/01/2022 Authors: Sumowski J; Levy S; Dvorak E; Sand IK; Brandstadter R; Lublin F; Miller A; Sandry J
  • Correction to: Functional connectivity in reward circuitry and symptoms of anhedonia as therapeutic targets in depression with high inflammation: evidence from a dopamine challenge study.
    Mol Psychiatry Volume: 27 Page(s): 4122
    10/01/2022 Authors: Bekhbat M; Li Z; Mehta ND; Treadway MT; Lucido MJ; Woolwine BJ; Haroon E; Miller AH; Felger JC
  • A network analysis of self-reported psychoneurological symptoms in patients with head and neck cancer undergoing intensity-modulated radiotherapy.
    Cancer Volume: 128 Page(s): 3734 - 3743
    10/01/2022 Authors: Lin Y; Bruner DW; Paul S; Miller AH; Saba NF; Higgins KA; Shin DM; Zhang W; Miaskowski C; Xiao C
  • Functional connectivity in reward circuitry and symptoms of anhedonia as therapeutic targets in depression with high inflammation: evidence from a dopamine challenge study.
    Mol Psychiatry Volume: 27 Page(s): 4113 - 4121
    10/01/2022 Authors: Bekhbat M; Li Z; Mehta ND; Treadway MT; Lucido MJ; Woolwine BJ; Haroon E; Miller AH; Felger JC
  • Cellular and immunometabolic mechanisms of inflammation in depression: Preliminary findings from single cell RNA sequencing and a tribute to Bruce McEwen.
    Neurobiol Stress Volume: 19 Page(s): 100462
    07/01/2022 Authors: Bekhbat M; Ulukaya GB; Bhasin MK; Felger JC; Miller AH
  • Cancer-related inflammation and depressive symptoms: Systematic review and meta-analysis.
    Cancer Volume: 128 Page(s): 2504 - 2519
    07/01/2022 Authors: McFarland DC; Doherty M; Atkinson TM; O'Hanlon R; Breitbart W; Nelson CJ; Miller AH
  • DNA methylation signature of chronic low-grade inflammation and its role in cardio-respiratory diseases.
    Nat Commun Volume: 13 Page(s): 2408
    05/03/2022 Authors: Wielscher M; Mandaviya PR; Kuehnel B; Joehanes R; Mustafa R; Robinson O; Zhang Y; Bodinier B; Walton E; Mishra PP
  • A Delphi-method-based consensus guideline for definition of treatment-resistant depression for clinical trials.
    Mol Psychiatry Volume: 27 Page(s): 1286 - 1299
    03/01/2022 Authors: Sforzini L; Worrell C; Kose M; Anderson IM; Aouizerate B; Arolt V; Bauer M; Baune BT; Blier P; Cleare AJ
  • Lenzilumab in hospitalised patients with COVID-19 pneumonia (LIVE-AIR): a phase 3, randomised, placebo-controlled trial.
    Lancet Respir Med Volume: 10 Page(s): 237 - 246
    03/01/2022 Authors: Temesgen Z; Burger CD; Baker J; Polk C; Libertin CR; Kelley CF; Marconi VC; Orenstein R; Catterson VM; Aronstein WS
  • Potential use of albumin and neutrophil-to-lymphocyte ratio to guide the evaluation and treatment of cancer-related depression and anxiety.
    Psychooncology Volume: 31 Page(s): 306 - 315
    02/01/2022 Authors: McFarland DC; Applebaum AJ; Bengtsen E; Alici Y; Breitbart W; Miller AH; Nelson C
  • Exercise and Cognitive Training Intervention Improves Self-Care, Quality of Life and Functional Capacity in Persons With Heart Failure.
    J Appl Gerontol Volume: 41 Page(s): 486 - 495
    02/01/2022 Authors: Gary RA; Paul S; Corwin E; Butts B; Miller AH; Hepburn K; Waldrop D
  • Transcriptomic signatures of psychomotor slowing in peripheral blood of depressed patients: evidence for immunometabolic reprogramming.
    Mol Psychiatry Volume: 26 Page(s): 7384 - 7392
    12/01/2021 Authors: Bekhbat M; Goldsmith DR; Woolwine BJ; Haroon E; Miller AH; Felger JC
  • A Pilot Study of Hypofractionated Simultaneous Integrated Boost Radiotherapy in Stage 0-IIIB Breast Cancer Patients
    Volume: 111 Page(s): E201 - E202
    11/01/2021 Authors: Lin JY; Yang X; Miller AH; Godette KD; Kahn ST; Brown G; Green I; Henry S; Liu T; Torres M
  • Outcomes Stratification of Head and Neck Cancer Using Pre- and Post-Treatment DNA Methylation in Peripheral Blood.
    Int J Radiat Oncol Biol Phys Volume: 111 Page(s): S143 - S144
    11/01/2021 Authors: Qian DC; Ulrich BC; Peng G; Zhao H; Conneely KN; Miller AH; Bruner DW; Eldridge RC; Wommack EC; Higgins KA
  • A Pilot Study of Hypofractionated Simultaneous Integrated Boost Radiotherapy in Stage 0-IIIB Breast Cancer Patients.
    Int J Radiat Oncol Biol Phys Volume: 111 Page(s): e201 - e202
    11/01/2021 Authors: Lin JY; Yang X; Miller AH; Godette KD; Kahn ST; Brown G; Green I; Henry S; Liu T; Torres M
  • Caregiver subjective and physiological markers of stress and patient heart failure severity in family care dyads.
    Psychoneuroendocrinology Volume: 133 Page(s): 105399
    11/01/2021 Authors: Bidwell JT; Hostinar CE; Higgins MK; Abshire MA; Cothran F; Butts B; Miller AH; Corwin E; Dunbar SB
  • The interaction of lipids and inflammatory markers predict negative symptom severity in patients with schizophrenia.
    NPJ Schizophr Volume: 7 Page(s): 50
    10/20/2021 Authors: Goldsmith DR; Massa N; Miller BJ; Miller AH; Duncan E
  • SNP's association with fatigue and physical activity in head and neck cancer patients: a pilot study for inflammatory mechanisms
    Volume: 30 Page(s): S147 - S147
    10/01/2021 Authors: Xiao C; Ye Y; Miller A; Higgins K; Saba N; Zhao H; Gary R; Withycombee J; Wommack E; Felger J
  • Plasma Metabolic Phenotypes of HPV-Associated versus Smoking-Associated Head and Neck Cancer and Patient Survival.
    Cancer Epidemiol Biomarkers Prev Volume: 30 Page(s): 1858 - 1866
    10/01/2021 Authors: Eldridge RC; Uppal K; Hayes DN; Smith MR; Hu X; Qin ZS; Beitler JJ; Miller AH; Wommack EC; Higgins KA
  • Epigenetic age acceleration, fatigue, and inflammation in patients undergoing radiation therapy for head and neck cancer: A longitudinal study.
    Cancer Volume: 127 Page(s): 3361 - 3371
    09/15/2021 Authors: Xiao C; Beitler JJ; Peng G; Levine ME; Conneely KN; Zhao H; Felger JC; Wommack EC; Chico CE; Jeon S
  • Kynurenines increase MRS metabolites in basal ganglia and decrease resting-state connectivity in frontostriatal reward circuitry in depression.
    Transl Psychiatry Volume: 11 Page(s): 456
    09/04/2021 Authors: Chen X; Beltran DJ; Tsygankova VD; Woolwine BJ; Patel T; Baer W; Felger JC; Miller AH; Haroon E
  • Association of Epigenetic Age Acceleration With Risk Factors, Survival, and Quality of Life in Patients With Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys Volume: 111 Page(s): 157 - 167
    09/01/2021 Authors: Xiao C; Miller AH; Peng G; Levine ME; Conneely KN; Zhao H; Eldridge RC; Wommack EC; Jeon S; Higgins KA
  • Capillary electrochromatography-mass spectrometry of kynurenine pathway metabolites.
    J Chromatogr A Volume: 1651 Page(s): 462294
    08/16/2021 Authors: Chawdhury ASMMR; Shamsi SA; Miller A; Liu A
  • Aiding and Abetting Anhedonia: Impact of Inflammation on the Brain and Pharmacological Implications.
    Pharmacol Rev Volume: 73 Page(s): 1084 - 1117
    07/01/2021 Authors: Lucido MJ; Bekhbat M; Goldsmith DR; Treadway MT; Haroon E; Felger JC; Miller AH
  • A Longitudinal Analysis of Inflammation and Depression in Patients With Metastatic Lung Cancer: Associations With Survival.
    Biol Res Nurs Volume: 23 Page(s): 301 - 310
    07/01/2021 Authors: McFarland DC; Miller AH; Nelson C
  • The role of the gut microbiome in cancer-related fatigue: pilot study on epigenetic mechanisms.
    Support Care Cancer Volume: 29 Page(s): 3173 - 3182
    06/01/2021 Authors: Xiao C; Fedirko V; Beitler J; Bai J; Peng G; Zhou C; Gu J; Zhao H; Lin I-H; Chico CE
  • The Immunology of Stress and the Impact of Inflammation on the Brain and Behavior.
    BJPsych Adv Volume: 27 Page(s): 158 - 165
    05/01/2021 Authors: Ravi M; Miller AH; Michopoulos V
  • Remembering Bruce S. McEwen - A tribute from psychoneuroimmunology.
    Brain Behav Immun Volume: 94 Page(s): 11 - 14
    05/01/2021 Authors: Dhabhar FS; Danese A; Felger JC; Miller AH
  • Chronically elevated depressive symptoms interact with acute increases in inflammation to predict worse neurocognition among people with HIV.
    J Neurovirol Volume: 27 Page(s): 160 - 167
    02/01/2021 Authors: Saloner R; Paolillo EW; Heaton RK; Grelotti DJ; Stein MB; Miller AH; Atkinson JH; Letendre SL; Ellis RJ; Grant I
  • Prognostic implications of depression and inflammation in patients with metastatic lung cancer.
    Future Oncol Volume: 17 Page(s): 183 - 196
    01/01/2021 Authors: McFarland DC; Saracino RM; Miller AH; Breitbart W; Rosenfeld B; Nelson C
  • Risk Factors for Post-traumatic Stress Disorder After Breast Cancer Diagnosis and Treatment Among African American Women: A Longitudinal Study
    Volume: 29 Page(s): A5 - A5
    12/01/2020 Authors: Miller A; Subhedar P; Stevens JS
  • High Inflammation and Metabolic Dysfunction are Associated With Increased Negative Symptoms in Patients With Schizophrenia
    Volume: 45 Page(s): 342 - 343
    12/01/2020 Authors: Goldsmith D; Massa N; Miller B; Pearce B; Miller A; Duncan E
  • Metabolic differences between human papillomavirus-related and smoking-related squamous cell carcinoma of the head and neck independently predict overall patient survival.
    Volume: 80
    12/01/2020 Authors: Eldridge RC; Uppal K; Beitler J; Higgins K; Wommack EC; Shin DM; Saba NF; Miller A; Bruner DW; Xiao C
  • Early childhood adversity in adult patients with metastatic lung cancer: Cross-sectional analysis of symptom burden and inflammation.
    Brain Behav Immun Volume: 90 Page(s): 167 - 173
    11/01/2020 Authors: McFarland DC; Nelson C; Miller AH
  • Trial failures of anti-inflammatory drugs in depression.
    Lancet Psychiatry Volume: 7 Page(s): 837
    10/01/2020 Authors: Miller AH; Pariante CM
  • Gut Microbiome Associated with the Psychoneurological Symptom Cluster in Patients with Head and Neck Cancers.
    Cancers (Basel) Volume: 12
    09/06/2020 Authors: Bai J; Bruner DW; Fedirko V; Beitler JJ; Zhou C; Gu J; Zhao H; Lin I-H; Chico CE; Higgins KA
  • Gene signatures in peripheral blood immune cells related to insulin resistance and low tyrosine metabolism define a sub-type of depression with high CRP and anhedonia.
    Brain Behav Immun Volume: 88 Page(s): 161 - 165
    08/01/2020 Authors: Bekhbat M; Treadway MT; Goldsmith DR; Woolwine BJ; Haroon E; Miller AH; Felger JC
  • Pilot study of combined aerobic and resistance exercise on fatigue for patients with head and neck cancer: Inflammatory and epigenetic changes.
    Brain Behav Immun Volume: 88 Page(s): 184 - 192
    08/01/2020 Authors: Xiao C; Beitler JJ; Higgins KA; Chico CE; Withycombe JS; Zhu Y; Zhao H; Lin I-H; Li F; Jeon S
  • Depression-free after Interferon- exposure indicates less incidence of depressive disorder: A longitudinal study in Taiwan.
    Brain Behav Immun Volume: 88 Page(s): 125 - 131
    08/01/2020 Authors: Sun C-F; Chiu W-C; Chen P-C; Chang H-C; Guu T-W; Shityakov S; Miller AH; Felger JC; Chang JP-C; Su K-P
  • Identifying Immunophenotypes of Inflammation in Depression: Dismantling the Monolith.
    Biol Psychiatry Volume: 88 Page(s): 136 - 138
    07/15/2020 Authors: Felger JC; Miller AH
  • Posttraumatic stress disorder and breast cancer: Risk factors and the role of inflammation and endocrine function.
    Cancer Volume: 126 Page(s): 3181 - 3191
    07/15/2020 Authors: Brown LC; Murphy AR; Lalonde CS; Subhedar PD; Miller AH; Stevens JS
  • GENE SIGNATURES RELATED TO INSULIN SIGNALING AND TYROSINE METABOLISM DEFINE A SUB-TYPE OF DEPRESSION WITH ANHEDONIA AND HIGH CRP
    Volume: 82 Page(s): A197 - A197
    07/01/2020 Authors: Bekhbat M; Goldsmith DR; Treadway MT; Woolwine BJ; Haroon E; Miller AH; Felger JC
  • Association Among Glucocorticoid Receptor Sensitivity, Fatigue, and Inflammation in Patients With Head and Neck Cancer.
    Psychosom Med Volume: 82 Page(s): 508 - 516
    06/01/2020 Authors: Xiao C; Eldridge RC; Beitler JJ; Higgins KA; Chico CE; Felger JC; Wommack EC; Knobf T; Saba NF; Shin DM
  • What does plasma CRP tell us about peripheral and central inflammation in depression?
    Mol Psychiatry Volume: 25 Page(s): 1301 - 1311
    06/01/2020 Authors: Felger JC; Haroon E; Patel TA; Goldsmith DR; Wommack EC; Woolwine BJ; Le N-A; Feinberg R; Tansey MG; Miller AH
  • Breast cancer patient reported outcomes, depression, and objective measures of breast cosmesis.
    Volume: 38
    05/20/2020 Authors: McManus S; Lin JY; Bhave MA; Brown G; Green I; Yang X; Liu T; Miller AH; Torres MA
  • Physical problem list accompanying the distress thermometer: Its associations with psychological symptoms and survival in patients with metastatic lung cancer.
    Psychooncology Volume: 29 Page(s): 910 - 919
    05/01/2020 Authors: McFarland DC; Jutagir DR; Miller A; Nelson C
  • Associations among peripheral and central kynurenine pathway metabolites and inflammation in depression.
    Neuropsychopharmacology Volume: 45 Page(s): 998 - 1007
    05/01/2020 Authors: Haroon E; Welle JR; Woolwine BJ; Goldsmith DR; Baer W; Patel T; Felger JC; Miller AH
  • Tumor Mutation Burden and Depression in Lung Cancer: Association With Inflammation.
    J Natl Compr Canc Netw Volume: 18 Page(s): 434 - 442
    04/01/2020 Authors: McFarland DC; Jutagir DR; Miller AH; Breitbart W; Nelson C; Rosenfeld B
  • Inflammatory markers are associated with psychomotor slowing in patients with schizophrenia compared to healthy controls.
    NPJ Schizophr Volume: 6 Page(s): 8
    04/01/2020 Authors: Goldsmith DR; Massa N; Pearce BD; Wommack EC; Alrohaibani A; Goel N; Cuthbert B; Fargotstein M; Felger JC; Haroon E
  • Instruments for determining clinically relevant fatigue in breast cancer patients during radiotherapy.
    Breast Cancer Volume: 27 Page(s): 197 - 205
    03/01/2020 Authors: Andic F; Miller AH; Brown G; Chu L; Lin J; Liu T; Sertdemir Y; Torres MA
  • An Intervention to Improve Physical Function and Caregiver Perceptions in Family Caregivers of Persons With Heart Failure.
    J Appl Gerontol Volume: 39 Page(s): 181 - 191
    02/01/2020 Authors: Gary R; Dunbar SB; Higgins M; Butts B; Corwin E; Hepburn K; Butler J; Miller AH
  • Beyond depression: the expanding role of inflammation in psychiatric disorders.
    World Psychiatry Volume: 19 Page(s): 108 - 109
    02/01/2020 Authors: Miller AH
  • Depression and Inflammation in Patients With Lung Cancer: A Comparative Analysis of Acute Phase Reactant Inflammatory Markers.
    Psychosomatics Volume: 61 Page(s): 527 - 537
    01/01/2020 Authors: McFarland DC; Breitbart W; Miller AH; Nelson C
  • Chronic inflammation in the etiology of disease across the life span.
    Nat Med Volume: 25 Page(s): 1822 - 1832
    12/01/2019 Authors: Furman D; Campisi J; Verdin E; Carrera-Bastos P; Targ S; Franceschi C; Ferrucci L; Gilroy DW; Fasano A; Miller GW
  • Full axillary lymph node dissection and increased breast epidermal thickness 1 year after radiation therapy for breast cancer.
    J Surg Oncol Volume: 120 Page(s): 1397 - 1403
    12/01/2019 Authors: Lin JY; Yang X; Serra M; Miller AH; Godette KD; Kahn ST; Henry S; Brown G; Liu T; Torres MA
  • Inflammation and decreased functional connectivity in a widely-distributed network in depression: Centralized effects in the ventral medial prefrontal cortex.
    Brain Behav Immun Volume: 80 Page(s): 657 - 666
    08/01/2019 Authors: Yin L; Xu X; Chen G; Mehta ND; Haroon E; Miller AH; Luo Y; Li Z; Felger JC
  • Exercise and Cognitive Training as a Strategy to Improve Neurocognitive Outcomes in Heart Failure: A Pilot Study.
    Am J Geriatr Psychiatry Volume: 27 Page(s): 809 - 819
    08/01/2019 Authors: Gary RA; Paul S; Corwin E; Butts B; Miller AH; Hepburn K; Williams B; Waldrop-Valverde D
  • Depression and inflammation among epidermal growth factor receptor (EGFR) mutant nonsmall cell lung cancer patients.
    Psychooncology Volume: 28 Page(s): 1461 - 1469
    07/01/2019 Authors: McFarland DC; Jutagir DR; Rosenfeld B; Pirl W; Miller AH; Breitbart W; Nelson C
  • Inflammation Effects on Striatal Dopamine: Implications for Late Life Depression
    Volume: 85 Page(s): S42 - S43
    05/15/2019 Authors: Felger J; Haroon E; Miller A; Li Z
  • Relationships Between Inflammatory Markers and Kynurenine Metabolites in Patients With Schizophrenia but Not Healthy Controls
    Volume: 85 Page(s): S365 - S365
    05/15/2019 Authors: Goldsmith D; Massa N; Pearce B; Wommack E; Alrohaibani A; Goel N; Cuthbert B; Fargotstein M; Barr DB; Panuwet P
  • 'Inflammaging' in Depression - Morphological, Metabolic and Behavioral Consequences
    Volume: 85 Page(s): S93 - S94
    05/15/2019 Authors: Haroon E; Chen X; Kim AH; Woolwine B; Patel T; Felger JC; Miller A
  • FromInflammation to Anhedonia - Role of Glutamate, Regional Homogeneity and Network Dysfunction
    Volume: 85 Page(s): S59 - S59
    05/15/2019 Authors: Haroon E; Chen X; Kim AH; Woolwine B; Patel T; Li Z; Felger J; Miller A
  • The effects of roux en y gastric bypass surgery on neurobehavioral symptom domains associated with severe obesity.
    Physiol Behav Volume: 204 Page(s): 86 - 92
    05/15/2019 Authors: Musselman D; Shenvi N; Manatunga A; Miller AH; Lin E; Gletsu-Miller N
  • C REACTIVE PROTEIN AND ITS ASSOCIATION WITH DEPRESSION IN PATIENTS RECEIVING TREATMENT FOR METASTATIC LUNG CANCER
    Volume: 81 Page(s): A113 - A114
    05/01/2019 Authors: McFarland D; Rosenfeld B; Nelson C; Miller A
  • Can't or Won't? Immunometabolic Constraints on Dopaminergic Drive.
    Trends Cogn Sci Volume: 23 Page(s): 435 - 448
    05/01/2019 Authors: Treadway MT; Cooper JA; Miller AH
  • What's in a name? How about being listed in the "Psychiatry" category in Clarivate's Journal Citation Index!
    Brain Behav Immun Volume: 78 Page(s): 3 - 4
    05/01/2019 Authors: Pariante CM; Harrison NA; Miller AH; Spencer SJ; Su K-P; Pittman QJ
  • C-reactive protein and its association with depression in patients receiving treatment for metastatic lung cancer.
    Cancer Volume: 125 Page(s): 779 - 787
    03/01/2019 Authors: McFarland DC; Shaffer K; Breitbart W; Rosenfeld B; Miller AH
  • Association of baseline inflammatory markers and the development of negative symptoms in individuals at clinical high risk for psychosis.
    Brain Behav Immun Volume: 76 Page(s): 268 - 274
    02/01/2019 Authors: Goldsmith DR; Haroon E; Miller AH; Addington J; Bearden C; Cadenhead K; Cannon T; Cornblatt B; Mathalon D; McGlashan T
  • Complement Activation During Early Pregnancy and Clinical Predictors of Preterm Birth in African American Women.
    J Perinat Neonatal Nurs Volume: 33 Page(s): E15 - E26
    01/01/2019 Authors: Dunn AB; Dunlop AL; Miller AH; Hogue CJ; Crofton JM; Corwin EJ
  • Longitudinal association of inflammation with depressive symptoms: A 7-year cross-lagged twin difference study.
    Brain Behav Immun Volume: 75 Page(s): 200 - 207
    01/01/2019 Authors: Huang M; Su S; Goldberg J; Miller AH; Levantsevych OM; Shallenberger L; Pimple P; Pearce B; Bremner JD; Vaccarino V
  • Glucose and lipid-related biomarkers and the antidepressant response to infliximab in patients with treatment-resistant depression.
    Psychoneuroendocrinology Volume: 98 Page(s): 222 - 229
    12/01/2018 Authors: Bekhbat M; Chu K; Le N-A; Woolwine BJ; Haroon E; Miller AH; Felger JC
  • Medulla Dose is Positively Associated with Sensation of Thirst & Midbrain Dose is Inversely Associated with Pain: Prospectively-Collected Patient-Reported Toxicities and Brainstem Dose in Head and Neck Cancer Radiation Therapy
    Volume: 102 Page(s): E198 - E198
    11/01/2018 Authors: Ferris MJ; Switchenko J; Xiao C; McDonald MW; Eaton BR; Higgins KA; Press RH; Tian S; Steuer C; Baddour HM
  • Differential regulation of NF-kB and IRF target genes as they relate to fatigue in patients with head and neck cancer.
    Brain Behav Immun Volume: 74 Page(s): 291 - 295
    11/01/2018 Authors: Xiao C; Beitler JJ; Higgins KA; Wommack EC; Saba NF; Shin DM; Bruner DW; Miller AH; Cole S
  • Latent class analysis of fatigue in patients with head and neck cancer
    Volume: 27 Page(s): S63 - S63
    10/01/2018 Authors: Xiao C; Eldridge R; Higgins K; Saba N; Shin D; Miller A; Bruner D; Beitler J
  • What's CRP got to do with it? Tackling the complexities of the relationship between CRP and depression.
    Brain Behav Immun Volume: 73 Page(s): 163 - 164
    10/01/2018 Authors: Felger JC; Haroon E; Miller AH
  • Increased inflammation and brain glutamate define a subtype of depression with decreased regional homogeneity, impaired network integrity, and anhedonia.
    Transl Psychiatry Volume: 8 Page(s): 189
    09/10/2018 Authors: Haroon E; Chen X; Li Z; Patel T; Woolwine BJ; Hu XP; Felger JC; Miller AH
  • TNF- and IL-6 are associated with the deficit syndrome and negative symptoms in patients with chronic schizophrenia.
    Schizophr Res Volume: 199 Page(s): 281 - 284
    09/01/2018 Authors: Goldsmith DR; Haroon E; Miller AH; Strauss GP; Buckley PF; Miller BJ
  • Association of T and non-T cell cytokines with anhedonia: Role of gender differences.
    Psychoneuroendocrinology Volume: 95 Page(s): 1 - 7
    09/01/2018 Authors: Jha MK; Miller AH; Minhajuddin A; Trivedi MH
  • Antidepressant treatment resistance is associated with increased inflammatory markers in patients with major depressive disorder.
    Psychoneuroendocrinology Volume: 95 Page(s): 43 - 49
    09/01/2018 Authors: Haroon E; Daguanno AW; Woolwine BJ; Goldsmith DR; Baer WM; Wommack EC; Felger JC; Miller AH
  • Associations among human papillomavirus, inflammation, and fatigue in patients with head and neck cancer.
    Cancer Volume: 124 Page(s): 3163 - 3170
    08/01/2018 Authors: Xiao C; Beitler JJ; Higgins KA; Glazer T; Huynh LK; Paul S; Felger JC; Wommack EC; Saba NF; Shin DM
  • Predicting fatigue levels of head and neck cancer patients with gene expression using machine learning
    Volume: 78
    07/01/2018 Authors: Eldridge RC; Miller AH; Bruner DW; Beitler JJ; Higgins KA; Wommack EC; Linh KH; Saba NF; Shin DM; Xiao C
  • Gender-Specific Association of IL-17 with Anhedonia in Depressed Outpatients: Findings From CO-MED Trial
    Volume: 83 Page(s): S63 - S63
    05/01/2018 Authors: Jha M; Miller A; Minhajuddin A; Trivedi M
  • Inflammation Effects on Motivation and Motor Activity: Dopamine as Mediator and Treatment Target
    Volume: 83 Page(s): S62 - S63
    05/01/2018 Authors: Miller A; Haroon E; Felger J
  • Association of Baseline Tumor Necrosis Factor and the Development of Negative Symptoms in Individuals at Clinical High Risk for Psychosis
    Volume: 83 Page(s): S330 - S331
    05/01/2018 Authors: Goldsmith D; Miller A; Addington J; Bearden C; Cadenhead K; Cannon T; Cornblatt B; Mathalon D; McGlashan T; Perkins D
  • Inflammation-associated Alterations in Corticostriatal Circuit Function in Breast Cancer: Relationship with Motivational and Motor Deficits and Fatigue
    Volume: 80 Page(s): A145 - A146
    04/01/2018 Authors: Felger J; Treadway MT; Li Z; Haroon E; Torres MA; Miller AH
  • Massage therapy decreases cancer-related fatigue: Results from a randomized early phase trial.
    Cancer Volume: 124 Page(s): 546 - 554
    02/01/2018 Authors: Kinkead B; Schettler PJ; Larson ER; Carroll D; Sharenko M; Nettles J; Edwards SA; Miller AH; Torres MA; Dunlop BW
  • Brainstem dose is associated with patient-reported acute fatigue in head and neck cancer radiation therapy.
    Radiother Oncol Volume: 126 Page(s): 100 - 106
    01/01/2018 Authors: Ferris MJ; Zhong J; Switchenko JM; Higgins KA; Cassidy RJ; McDonald MW; Eaton BR; Patel KR; Steuer CE; Baddour HM
  • HPV status is associated with fatigue at one year post IMRT for patients with head and neck cancer
    Volume: 26 Page(s): 45 - 45
    10/01/2017 Authors: Xiao C; Beitler JJ; Higgins KA; Saba NF; Shin DM; Linh KH; Glazer T; Miller AH; Bruner DW
  • A Prospective Longitudinal Study of Radiation TherapyeInduced Skin Toxicity and Long-term Fatigue in Breast Cancer Patients
    Volume: 99 Page(s): S4 - S4
    10/01/2017 Authors: Torres M; Miller AH; Xiao C; Lin J; Godette KD; Kahn ST; Han T; Mister D; Henry S; Yang X
  • Predictors of Breast Pain in Breast Cancer Patents One Year After Whole Breast Radiation Therapy
    Volume: 99 Page(s): E41 - E41
    10/01/2017 Authors: Parks J; Yang X; Zhang C; Chen Z; Miller AH; Godette KD; Kahn ST; Han T; Ali AN; Mister D
  • Full Axillary Lymph Node Dissection and Increased Breast Epidermal Thickness One Year After Radiation for Breast Cancer
    Volume: 99 Page(s): S217 - S218
    10/01/2017 Authors: Lin JY; Yang X; Noreen S; Miller AH; Godette KD; Kahn ST; Han T; Ali AN; Mister D; Henry S
  • Is C-reactive protein ready for prime time in the selection of antidepressant medications?
    Psychoneuroendocrinology Volume: 84 Page(s): 206
    10/01/2017 Authors: Miller AH; Trivedi MH; Jha MK
  • Depressive symptoms and inflammation are independent risk factors of fatigue in breast cancer survivors.
    Psychol Med Volume: 47 Page(s): 1733 - 1743
    07/01/2017 Authors: Xiao C; Miller AH; Felger J; Mister D; Liu T; Torres MA
  • The Microbiome and Complement Activation: A Mechanistic Model for Preterm Birth.
    Biol Res Nurs Volume: 19 Page(s): 295 - 307
    05/01/2017 Authors: Dunn AB; Dunlop AL; Hogue CJ; Miller A; Corwin EJ
  • A systematic review of the association between fatigue and genetic polymorphisms.
    Brain Behav Immun Volume: 62 Page(s): 230 - 244
    05/01/2017 Authors: Wang T; Yin J; Miller AH; Xiao C
  • Pathway Linking Depression & Inflammation: A 5-year Longitudinal Twin Difference Study
    CIRCULATION Volume: 135
    03/07/2017 Authors: Huang M; Su S; Goldberg J; Miller AH; Murrah NV; Shallenberger L; Pimple P; Bremner JD; Vaccarino V
  • ASSOCIATION BETWEEN INFLAMMATORY MARKERS AND NEGATIVE SYMPTOMS IN INDIVIDUALS WITH PERSISTENT SYMPTOMS OF SCHIZOPHRENIA TREATED WITH CLOZAPINE
    SCHIZOPHRENIA BULLETIN Volume: 43 Page(s): S184 - S184
    03/01/2017 Authors: Goldsmith D; Kopelovich S; Novacek D; Widener J; Wommack E; Felger J; Miller A; Cotes R
  • Therapeutic Implications of Brain-Immune Interactions: Treatment in Translation.
    Neuropsychopharmacology Volume: 42 Page(s): 334 - 359
    01/01/2017 Authors: Miller AH; Haroon E; Felger JC
  • Inflammation, Glutamate, and Glia: A Trio of Trouble in Mood Disorders.
    Neuropsychopharmacology Volume: 42 Page(s): 193 - 215
    01/01/2017 Authors: Haroon E; Miller AH; Sanacora G
  • Pathogen-Host Defense in the Evolution of Depression: Insights into Epidemiology, Genetics, Bioregional Differences and Female Preponderance.
    Neuropsychopharmacology Volume: 42 Page(s): 5 - 27
    01/01/2017 Authors: Raison CL; Miller AH
  • Inflammation Effects on Brain Glutamate in Depression: Mechanistic Considerations and Treatment Implications.
    Curr Top Behav Neurosci Volume: 31 Page(s): 173 - 198
    01/01/2017 Authors: Haroon E; Miller AH
  • The Immunology of Behavior-Exploring the Role of the Immune System in Brain Health and Illness.
    Neuropsychopharmacology Volume: 42 Page(s): 1 - 4
    01/01/2017 Authors: Miller AH; Haroon E; Felger JC
  • Inflammation Effects on Glutamate as a Pathway to Neuroprogression in Mood Disorders.
    Mod Trends Pharmacopsychiatry Volume: 31 Page(s): 37 - 55
    01/01/2017 Authors: Haroon E; Miller AH
  • Impact of Ixekizumab Treatment on Depressive Symptoms and Systemic Inflammation in Patients with Moderate-to-Severe Psoriasis: An Integrated Analysis of Three Phase 3 Clinical Studies.
    Psychother Psychosom Volume: 86 Page(s): 260 - 267
    01/01/2017 Authors: Griffiths CEM; Fava M; Miller AH; Russell J; Ball SG; Xu W; Acharya N; Rapaport MH
  • Brain-Immune System Interactions Relevance to the Pathophysiology and Treatment of Neuropsychiatric Disorders
    Page(s): 177 - 208
    01/01/2017 Authors: Dhabhar FS; Raison CL; Miller AH
  • Association Between Inflammatory Markers and Negative Symptoms in Individuals With Persistent Symptoms of Schizophrenia Treated With Clozapine
    NEUROPSYCHOPHARMACOLOGY Volume: 41 Page(s): S390 - S391
    12/01/2016 Authors: Goldsmith D; Kopelovich S; Novacek D; Widener J; Wommack E; Felger J; Miller A; Cotes R
  • Interferon-alpha-induced inflammation is associated with reduced glucocorticoid negative feedback sensitivity and depression in patients with hepatitis C virus.
    Physiol Behav Volume: 166 Page(s): 14 - 21
    11/01/2016 Authors: Felger JC; Haroon E; Woolwine BJ; Raison CL; Miller AH
  • Risk factors for fatigue changes during acute phase of IMRT for patients with head and neck cancer
    QUALITY OF LIFE RESEARCH Volume: 25 Page(s): 156 - 156
    10/01/2016 Authors: Xiao C; Beitler JJ; Higgins KA; Saba NF; Glazer T; Kowalski J; Miller AH; Bruner DW
  • CNS Dose Is Not Associated With Treatment-Related Fatigue in Patients Undergoing Radiation Therapy for Head and Neck Cancer
    Volume: 96 Page(s): E357 - E357
    10/01/2016 Authors: Ferris MJ; Zhong J; Switchenko J; Higgins KA; McDonald MW; Eaton BR; Miller AH; Bruner DW; Xiao C; Beitler JJ
  • Persistent Fatigue Is Associated With Persistent Peripheral Inflammation in Patients With Squamous Cell Carcinoma of the Head and Neck Cancer up to 3 Months Post-Intensity Modulated Radiation Therapy
    Volume: 96 Page(s): E348 - E348
    10/01/2016 Authors: Xiao C; Beitler JJ; Higgins KA; Glazer T; Wommack E; Shin DM; Saba NF; Bruner DW; Miller AH
  • Persistent Fatigue Is Associated With Persistent Peripheral Inflammation in Patients With Squamous Cell Carcinoma of the Head and Neck Cancer up to 3 Months Post-Intensity Modulated Radiation Therapy.
    Int J Radiat Oncol Biol Phys Volume: 96 Page(s): E348
    10/01/2016 Authors: Xiao C; Beitler JJ; Higgins KA; Glazer T; Wommack E; Shin DM; Saba NF; Watkins Bruner D; Miller AH
  • CNS Dose Is Not Associated With Treatment-Related Fatigue in Patients Undergoing Radiation Therapy for Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys Volume: 96 Page(s): E357
    10/01/2016 Authors: Ferris MJ; Zhong J; Switchenko J; Higgins KA; McDonald MW; Eaton BR; Miller AH; Bruner DW; Xiao C; Beitler JJ
  • Conceptual convergence: increased inflammation is associated with increased basal ganglia glutamate in patients with major depression.
    Mol Psychiatry Volume: 21 Page(s): 1351 - 1357
    10/01/2016 Authors: Haroon E; Fleischer CC; Felger JC; Chen X; Woolwine BJ; Patel T; Hu XP; Miller AH
  • Inflammation is associated with decreased functional connectivity within corticostriatal reward circuitry in depression.
    Mol Psychiatry Volume: 21 Page(s): 1358 - 1365
    10/01/2016 Authors: Felger JC; Li Z; Haroon E; Woolwine BJ; Jung MY; Hu X; Miller AH
  • Inflammatory markers are associated with decreased psychomotor speed in patients with major depressive disorder.
    Brain Behav Immun Volume: 56 Page(s): 281 - 288
    08/01/2016 Authors: Goldsmith DR; Haroon E; Woolwine BJ; Jung MY; Wommack EC; Harvey PD; Treadway MT; Felger JC; Miller AH
  • Short and long-term response and remission of depressive symptoms in psoriasis patients treated continuously with ixekizumab in UNCOVER-3
    Volume: 30 Page(s): 39 - 40
    07/01/2016 Authors: Griffiths CE; Fava M; Mrowietz U; Miller A; Russell J; Ball S; Zhang L; Acharya N; Rapaport M
  • Impact of ixekizumab treatment on depressive symptoms: An integrated analysis of three phase 3 clinical studies in patients with moderate-to-severe psoriasis
    Volume: 74 Page(s): AB253 - AB253
    05/01/2016 Authors: Griffiths C; Fava M; Miller A; Russell J; Ball S; Xu I; Acharya N; Rapaport M
  • The Impact of Compassion Meditation on Medical Student Well-Being and Immune Function
    Volume: 79 Page(s): 340S - 340S
    05/01/2016 Authors: Mascaro JS; Kelley S; Darcher A; Negi LT; Worthman C; Miller A; Raison C
  • Inflammatory Markers are Associated with Decreased Psychomotor Speed in Patients with Major Depressive Disorder
    Volume: 79 Page(s): 53S - 53S
    05/01/2016 Authors: Goldsmith DR; Haroon E; Woolwine BJ; Jung MY; Wommack E; Harvey PD; Treadway MT; Felger JC; Miller AH
  • Impact of Inflammation-induced Glutamate Increases on Neuroprogression Among Patients with Mood Disorders
    Volume: 79 Page(s): 310S - 310S
    05/01/2016 Authors: Haroon E; Miller AH
  • Inflammatory mechanisms contribute to microembolism-induced anxiety-like and depressive-like behaviors.
    Behav Brain Res Volume: 303 Page(s): 160 - 167
    04/15/2016 Authors: Nemeth CL; Miller AH; Tansey MG; Neigh GN
  • DEPRESSION AND INFLAMMATION: WHICH COMES FIRST? A LONGITUDINAL MONOZYGOTIC TWIN DIFFERENCE STUDY
    Volume: 78 Page(s): A25 - A26
    04/01/2016 Authors: Su S; Goldberg J; Miller AH; Murrah NV; Shallenberger L; Pimple P; Bremner JD; Vaccarino V
  • Fatigue is associated with inflammation in patients with head and neck cancer before and after intensity-modulated radiation therapy.
    Brain Behav Immun Volume: 52 Page(s): 145 - 152
    02/01/2016 Authors: Xiao C; Beitler JJ; Higgins KA; Conneely K; Dwivedi B; Felger J; Wommack EC; Shin DM; Saba NF; Ong LY
  • Association of childhood trauma with fatigue, depression, stress, and inflammation in breast cancer patients undergoing radiotherapy.
    Psychooncology Volume: 25 Page(s): 187 - 193
    02/01/2016 Authors: Han TJ; Felger JC; Lee A; Mister D; Miller AH; Torres MA
  • A prospective study of quality of life in breast cancer patients undergoing radiation therapy.
    Adv Radiat Oncol Volume: 1 Page(s): 10 - 16
    01/01/2016 Authors: Xiao C; Miller AH; Felger J; Mister D; Liu T; Torres MA
  • The role of inflammation in depression: from evolutionary imperative to modern treatment target.
    Nat Rev Immunol Volume: 16 Page(s): 22 - 34
    01/01/2016 Authors: Miller AH; Raison CL
  • Inflammation-Related Decreases in Dopamine and Effects on Corticostriatal Reward Circuitry: Evidence from Humans and Non-Human Primates
    Volume: 40 Page(s): S37 - S37
    12/01/2015 Authors: Felger J
  • Inflammatory Cytokines Are Associated with Decreased Psychomotor Speed in Female, but Not Male, Patients with Major Depression
    Volume: 40 Page(s): S339 - S340
    12/01/2015 Authors: Goldsmith D; Haroon E; Woolwine B; Jung M; Wommack E; Felger J; Miller A
  • Conceptual Convergence: Increased Inflammation is Associated with Increased Basal Ganglia Glutamate in Patients with Major Depression
    Volume: 40 Page(s): S335 - S336
    12/01/2015 Authors: Haroon E; Fleischer C; Chen X; Felger J; Woolwine B; Hu X; Miller A
  • Pain Intensity and Pain Interference in Patients With Lung Cancer: A Pilot Study of Biopsychosocial Predictors.
    Am J Clin Oncol Volume: 38 Page(s): 457 - 464
    10/01/2015 Authors: Dalton JA; Higgins MK; Miller AH; Keefe FJ; Khuri FR
  • Risk and Resilience: Animal Models Shed Light on the Pivotal Role of Inflammation in Individual Differences in Stress-Induced Depression.
    Biol Psychiatry Volume: 78 Page(s): 7 - 9
    07/01/2015 Authors: Felger JC; Haroon E; Miller AH
  • Inflammation-induced activation of the indoleamine 2,3-dioxygenase pathway: Relevance to cancer-related fatigue.
    Cancer Volume: 121 Page(s): 2129 - 2136
    07/01/2015 Authors: Kim S; Miller BJ; Stefanek ME; Miller AH
  • Inhibition of tumor necrosis factor improves sleep continuity in patients with treatment resistant depression and high inflammation.
    Brain Behav Immun Volume: 47 Page(s): 193 - 200
    07/01/2015 Authors: Weinberger JF; Raison CL; Rye DB; Montague AR; Woolwine BJ; Felger JC; Haroon E; Miller AH
  • Are Anti-inflammatory Therapies Viable Treatments for Psychiatric Disorders?: Where the Rubber Meets the Road.
    JAMA Psychiatry Volume: 72 Page(s): 527 - 528
    06/01/2015 Authors: Miller AH; Raison CL
  • Patterns and predictors of antidepressant use in ambulatory cancer patients with common solid tumors.
    Psychooncology Volume: 24 Page(s): 523 - 532
    05/01/2015 Authors: Fisch MJ; Zhao F; Manola J; Miller AH; Pirl WF; Wagner LI
  • Cytokines and Anhedonia: Subcortical Sources of Inflammatory Malaise
    Volume: 77 Page(s): 14S - 14S
    05/01/2015 Authors: Miller AH
  • Age-related increases in basal ganglia glutamate are associated with TNF, reduced motivation and decreased psychomotor speed during IFN-alpha treatment: Preliminary findings.
    Brain Behav Immun Volume: 46 Page(s): 17 - 22
    05/01/2015 Authors: Haroon E; Felger JC; Woolwine BJ; Chen X; Parekh S; Spivey JR; Hu XP; Miller AH
  • Inflammatory cytokine effects on neurotransmitters, neurocircuits, and behavior in depression
    JOURNAL OF NEUROIMMUNE PHARMACOLOGY Volume: 10 Page(s): S69 - S69
    04/01/2015 Authors: Felger JC; Haroon E; Woolwine BJ; Miller AH
  • Levodopa reverses cytokine-induced reductions in striatal dopamine release.
    Int J Neuropsychopharmacol Volume: 18
    01/31/2015 Authors: Felger JC; Hernandez CR; Miller AH
  • Two weeks of predatory stress induces anxiety-like behavior with co-morbid depressive-like behavior in adult male mice.
    Behav Brain Res Volume: 275 Page(s): 120 - 125
    12/15/2014 Authors: Burgado J; Harrell CS; Eacret D; Reddy R; Barnum CJ; Tansey MG; Miller AH; Wang H; Neigh GN
  • Levodopa Reverses Cytokine-induced Reductions in Striatal Dopamine Release
    Volume: 39 Page(s): S617 - S618
    12/01/2014 Authors: Felger J; Hernandez C; Miller A
  • Interaction of Aging and Inflammation is Associated with Increased Basal Ganglia Glutamate and Reduced Motivation and Motor Activity During Inteferon-Alpha Therapy
    Volume: 39 Page(s): S204 - S204
    12/01/2014 Authors: Haroon E; Felger JC; Woolwine BJ; Jung MY; Patel JD; Chen X; Hu XP; Miller AH
  • Increased Fatigue Is Associated With TNF and NF kappa B-Regulated Inflammatory Signaling in Patients With Head and Neck Cancer Receiving IMRT
    Volume: 90 Page(s): S571 - S571
    09/01/2014 Authors: Xiao C; Beitler JJ; Higgins KA; Felger J; Ong LY; Shin DM; Saba NF; Bruner DW; Miller AH
  • Use of high-resolution volumetric MR spectroscopic imaging in assessing treatment response of glioblastoma to an HDAC inhibitor.
    AJR Am J Roentgenol Volume: 203 Page(s): W158 - W165
    08/01/2014 Authors: Shim H; Wei L; Holder CA; Guo Y; Hu XP; Miller AH; Olson JJ
  • IFN-alpha-induced cortical and subcortical glutamate changes assessed by magnetic resonance spectroscopy.
    Neuropsychopharmacology Volume: 39 Page(s): 1777 - 1785
    06/01/2014 Authors: Haroon E; Woolwine BJ; Chen X; Pace TW; Parekh S; Spivey JR; Hu XP; Miller AH
  • The influence of childhood trauma on fatigue and depression in breast cancer patients during and after radiotherapy
    Volume: 32
    05/20/2014 Authors: Han TJ; Lee A; Mister D; Miller AH; Torres MA
  • The influence of radiotherapy on sleep disturbances in breast cancer patients.
    Volume: 32
    05/20/2014 Authors: Hanasoge S; Wang X; Chen Z; Mister D; Miller AH; Torres MA
  • Epigenetic changes associated with inflammation in breast cancer patients treated with chemotherapy.
    Brain Behav Immun Volume: 38 Page(s): 227 - 236
    05/01/2014 Authors: Smith AK; Conneely KN; Pace TWW; Mister D; Felger JC; Kilaru V; Akel MJ; Vertino PM; Miller AH; Torres MA
  • The Neurocircuitry of Inflammation in Depression
    Volume: 75 Page(s): 400S - 400S
    05/01/2014 Authors: Felger JC; Li Z; Haroon E; Brigitta G; Hu X; Miller A
  • Cytokine targets in the brain: impact on neurotransmitters and neurocircuits
    Volume: 28
    04/01/2014 Authors: Miller A
  • Decreased basal ganglia activation in subjects with chronic fatigue syndrome: association with symptoms of fatigue.
    PLoS One Volume: 9 Page(s): e98156
    01/01/2014 Authors: Miller AH; Jones JF; Drake DF; Tian H; Unger ER; Pagnoni G
  • Neurotherapeutic implications of brain-immune interactions.
    Neuropsychopharmacology Volume: 39 Page(s): 242 - 243
    01/01/2014 Authors: Felger JC; Miller AH
  • Increased Glutamate in the Dorsal Anterior Cingulate Cortex Is Associated with Anxiety Symptom Domain in MDD with High inflammation
    NEUROPSYCHOPHARMACOLOGY Volume: 38 Page(s): S222 - S223
    12/01/2013 Authors: Haroon E; Woolwine B; Chen X; Hu X; Miller AH
  • Testing the Cytokine Hypothesis of Depression: Trials and Tribulations
    NEUROPSYCHOPHARMACOLOGY Volume: 38 Page(s): S84 - S85
    12/01/2013 Authors: Miller AH
  • Improved separation and detection of picolinic acid and quinolinic acid by capillary electrophoresis-mass spectrometry: application to analysis of human cerebrospinal fluid.
    J Chromatogr A Volume: 1316 Page(s): 147 - 153
    11/05/2013 Authors: Wang X; Davis I; Liu A; Miller A; Shamsi SA
  • RISK FACTORS OF IMRT INDUCED FATIGUE IN HEAD AND NECK CANCER PATIENTS
    ONCOLOGY NURSING FORUM Volume: 40 Page(s): E440 - E441
    11/01/2013 Authors: Xiao C; Beitler J; Ong LY; Miller A; Bruner D
  • Recommendations for high-priority research on cancer-related fatigue in children and adults.
    J Natl Cancer Inst Volume: 105 Page(s): 1432 - 1440
    10/02/2013 Authors: Barsevick AM; Irwin MR; Hinds P; Miller A; Berger A; Jacobsen P; Ancoli-Israel S; Reeve BB; Mustian K; O'Mara A
  • Chronic interferon- decreases dopamine 2 receptor binding and striatal dopamine release in association with anhedonia-like behavior in nonhuman primates.
    Neuropsychopharmacology Volume: 38 Page(s): 2179 - 2187
    10/01/2013 Authors: Felger JC; Mun J; Kimmel HL; Nye JA; Drake DF; Hernandez CR; Freeman AA; Rye DB; Goodman MM; Howell LL
  • Perceived stress to predict for acute radiation-induced skin toxicity: The mind-body connection
    Volume: 31
    09/10/2013 Authors: Eaton BR; Liu T; Yang X; Mister D; Zhao Y; Miller AH; Long Q; Torres MA
  • A prospective study on behavioral symptoms' impact to the quality of life in patients with early-stage cancer receiving radiotherapy.
    J Clin Oncol Volume: 31 Page(s): 46
    09/10/2013 Authors: Felger J; Mister D; Liu T; Miller AH; Torres MA
  • Perceived stress to predict for acute radiation-induced skin toxicity: The mind-body connection.
    Volume: 31 Page(s): 62
    09/10/2013 Authors: Liu T; Yang X; Mister D; Zhao Y; Miller AH; Long Q; Torres MA
  • The impact of escitalopram on IL-2-induced neuroendocrine, immune, and behavioral changes in patients with malignant melanoma: preliminary findings.
    Neuropsychopharmacology Volume: 38 Page(s): 1921 - 1928
    09/01/2013 Authors: Musselman D; Royster EB; Wang M; Long Q; Trimble LM; Mann TK; Graciaa DS; McNutt MD; Auyeung NSF; Oliver L
  • Conceptual confluence: the kynurenine pathway as a common target for ketamine and the convergence of the inflammation and glutamate hypotheses of depression.
    Neuropsychopharmacology Volume: 38 Page(s): 1607 - 1608
    08/01/2013 Authors: Miller AH
  • Transcriptional signatures related to glucose and lipid metabolism predict treatment response to the tumor necrosis factor antagonist infliximab in patients with treatment-resistant depression.
    Brain Behav Immun Volume: 31 Page(s): 205 - 215
    07/01/2013 Authors: Mehta D; Raison CL; Woolwine BJ; Haroon E; Binder EB; Miller AH; Felger JC
  • Tyrosine metabolism during interferon-alpha administration: association with fatigue and CSF dopamine concentrations.
    Brain Behav Immun Volume: 31 Page(s): 153 - 160
    07/01/2013 Authors: Felger JC; Li L; Marvar PJ; Woolwine BJ; Harrison DG; Raison CL; Miller AH
  • Association of IL-12p70 and IL-6:IL-10 ratio with autism-related behaviors in 22q11.2 deletion syndrome: a preliminary report.
    Brain Behav Immun Volume: 31 Page(s): 76 - 81
    07/01/2013 Authors: Ross HE; Guo Y; Coleman K; Ousley O; Miller AH
  • Malaise, melancholia and madness: the evolutionary legacy of an inflammatory bias.
    Brain Behav Immun Volume: 31 Page(s): 1 - 8
    07/01/2013 Authors: Raison CL; Miller AH
  • Predictors of depression in breast cancer patients treated with radiation: role of prior chemotherapy and nuclear factor kappa B.
    Cancer Volume: 119 Page(s): 1951 - 1959
    06/01/2013 Authors: Torres MA; Pace TW; Liu T; Felger JC; Mister D; Doho GH; Kohn JN; Barsevick AM; Long Q; Miller AH
  • Interferon-Alpha-Induced Behavioral Changes Correlate with Increased Basal Ganglia Glutamate Which is in Turn Associated with Activation of the Kynurenine Pathway
    Volume: 73 Page(s): 230S - 230S
    05/01/2013 Authors: Miller A
  • Association between posttraumatic stress disorder and inflammation: a twin study.
    Brain Behav Immun Volume: 30 Page(s): 125 - 132
    05/01/2013 Authors: Plantinga L; Bremner JD; Miller AH; Jones DP; Veledar E; Goldberg J; Vaccarino V
  • Equipping Future Healthcare Team Leaders with Skills to Improve Post Discharge Outcomes; Implementing a Care Transitions Curriculum among Medical Residents.
    Volume: 61 Page(s): S157 - S157
    04/01/2013 Authors: Ohuabunwa U; Eskildsen M; Payne C; Bonsall J; Rimler E; Ilksoy N; Miller A
  • Cytokine targets in the brain: impact on neurotransmitters and neurocircuits.
    Depress Anxiety Volume: 30 Page(s): 297 - 306
    04/01/2013 Authors: Miller AH; Haroon E; Raison CL; Felger JC
  • The evolutionary significance of depression in Pathogen Host Defense (PATHOS-D).
    Mol Psychiatry Volume: 18 Page(s): 15 - 37
    01/01/2013 Authors: Raison CL; Miller AH
  • Role of inflammation in depression: implications for phenomenology, pathophysiology and treatment.
    Volume: 28 Page(s): 33 - 48
    01/01/2013 Authors: Raison CL; Miller AH
  • Do cytokines really sing the blues?
    Cerebrum Volume: 2013 Page(s): 10
    01/01/2013 Authors: Raison CL; Miller AH
  • A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers.
    JAMA Psychiatry Volume: 70 Page(s): 31 - 41
    01/01/2013 Authors: Raison CL; Rutherford RE; Woolwine BJ; Shuo C; Schettler P; Drake DF; Haroon E; Miller AH
  • Patterns of antidepressant use in patients with cancer: An analysis from SOAPP (E2Z02: Symptom Outcomes and Practice Patterns)
    JOURNAL OF CLINICAL ONCOLOGY Volume: 30
    12/01/2012 Authors: Fisch M; Zhao F; Manola J; Miller AH; Pirl WF; Wagner LI
  • Prospective Longitudinal Study of Radiation-induced Cutaneous Toxicity in Breast Cancer Patients Undergoing Breast Conserving Therapy
    Volume: 84 Page(s): S189 - S190
    11/01/2012 Authors: Torres M; Yang X; Pace T; Felger J; Godette KD; Stapleford L; Mister D; Kohn J; Miller A; Liu T
  • Dopaminergic mechanisms of reduced basal ganglia responses to hedonic reward during interferon alfa administration.
    Arch Gen Psychiatry Volume: 69 Page(s): 1044 - 1053
    10/01/2012 Authors: Capuron L; Pagnoni G; Drake DF; Woolwine BJ; Spivey JR; Crowe RJ; Votaw JR; Goodman MM; Miller AH
  • Molecular signatures of peripheral blood mononuclear cells during chronic interferon- treatment: relationship with depression and fatigue.
    Psychol Med Volume: 42 Page(s): 1591 - 1603
    08/01/2012 Authors: Felger JC; Cole SW; Pace TWW; Hu F; Woolwine BJ; Doho GH; Raison CL; Miller AH
  • Cytokine effects on the basal ganglia and dopamine function: the subcortical source of inflammatory malaise.
    Front Neuroendocrinol Volume: 33 Page(s): 315 - 327
    08/01/2012 Authors: Felger JC; Miller AH
  • Association of a polymorphism in the indoleamine- 2,3-dioxygenase gene and interferon--induced depression in patients with chronic hepatitis C.
    Mol Psychiatry Volume: 17 Page(s): 781 - 789
    07/01/2012 Authors: Smith AK; Simon JS; Gustafson EL; Noviello S; Cubells JF; Epstein MP; Devlin DJ; Qiu P; Albrecht JK; Brass CA
  • Patterns of antidepressant use in cancer patients (pts): An analysis from SOAPP (ECOG E2Z02: Symptom Outcomes and Practice Patterns)
    Volume: 30
    05/20/2012 Authors: Manola J; Zhao F; Miller AH; Pirl WF; Wagner LI; Fisch M
  • A prospective longitudinal study of cancer-related fatigue in patients undergoing breast-conserving surgery and radiation with or without chemotherapy for breast cancer
    Volume: 30
    05/20/2012 Authors: Torres MA; Pace T; Felger J; Liu T; Godette KD; Stapleford LJ; Mister D; Miller AH
  • Using proton MRSI to predict response to vorinostat treatment in recurrent GBM.
    Volume: 30
    05/20/2012 Authors: Shim H; Voloschin AD; Wei L; Hwang SN; Miller AH; Guo Y; Brat D; Holder CA; Read WL; Kopcewicz K
  • Neurobehavioral effects of interferon- in patients with hepatitis-C: symptom dimensions and responsiveness to paroxetine.
    Neuropsychopharmacology Volume: 37 Page(s): 1444 - 1454
    05/01/2012 Authors: McNutt MD; Liu S; Manatunga A; Royster EB; Raison CL; Woolwine BJ; Demetrashvili MF; Miller AH; Musselman DL
  • Changes in Tyrosine Metabolism are Associated with Fatigue in Interferon-Alpha-Treated Patients
    Volume: 71 Page(s): 304S - 305S
    04/15/2012 Authors: Felger JC; Woolwine BJ; Raison CL; Miller AH
  • Impact of cytokines on neurocircuits relevant to anxiety, depression, and fatigue in cancer patients
    CANCER RESEARCH Volume: 72
    04/15/2012 Authors: Miller A
  • Using proton MRSI to predict response of Vorinostat treatment in recurrent GBM
    CANCER RESEARCH Volume: 72
    04/15/2012 Authors: Shim H; Wei L; Hwang SN; Miller AH; Guo Y; Hoder CA; Read W; Kopcewicz K; Voloschin A; Brat DJ
  • Impact of cytokines on neurocircuits relevant to anxiety, depression, and fatigue in cancer patients
    CANCER RESEARCH Volume: 72
    04/15/2012 Authors: Miller A
  • Decreased basal ganglia activation in Chronic Fatigue Syndrome subjects is associated with increased fatigue
    Volume: 26
    04/01/2012 Authors: Unger ER; Miller AH; Jones JF; Drake DF; Tian H; Pagnoni G
  • Inhibition of the NF-B signaling pathway by the curcumin analog, 3,5-Bis(2-pyridinylmethylidene)-4-piperidone (EF31): anti-inflammatory and anti-cancer properties.
    Int Immunopharmacol Volume: 12 Page(s): 368 - 377
    02/01/2012 Authors: Olivera A; Moore TW; Hu F; Brown AP; Sun A; Liotta DC; Snyder JP; Yoon Y; Shim H; Marcus AI
  • Psychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behavior.
    Neuropsychopharmacology Volume: 37 Page(s): 137 - 162
    01/01/2012 Authors: Haroon E; Raison CL; Miller AH
  • Is depression an inflammatory disorder?
    Curr Psychiatry Rep Volume: 13 Page(s): 467 - 475
    12/01/2011 Authors: Raison CL; Miller AH
  • Activation of cAMP-protein kinase A abrogates STAT5-mediated inhibition of glucocorticoid receptor signaling by interferon-alpha.
    Brain Behav Immun Volume: 25 Page(s): 1716 - 1724
    11/01/2011 Authors: Pace TWW; Hu F; Miller AH
  • A prospective study of cancer-related fatigue in women undergoing radiotherapy for breast cancer.
    JOURNAL OF CLINICAL ONCOLOGY Volume: 29
    09/20/2011 Authors: Torres MA; Liu T; Chen H; Godette KD; Stapleford LJ; Mister D; Pace T; Miller AH
  • A prospective study of cancer-related fatigue in women undergoing radiotherapy for breast cancer.
    J Clin Oncol Volume: 29 Page(s): 110
    09/20/2011 Authors: Torres MA; Liu T; Chen H; Godette KD; Stapleford LJ; Mister D; Pace T; Miller AH
  • Early activation of p38 mitogen activated protein kinase is associated with interferon-alpha-induced depression and fatigue.
    Brain Behav Immun Volume: 25 Page(s): 1094 - 1098
    08/01/2011 Authors: Felger JC; Alagbe O; Pace TWW; Woolwine BJ; Hu F; Raison CL; Miller AH
  • Immune system to brain signaling: neuropsychopharmacological implications.
    Pharmacol Ther Volume: 130 Page(s): 226 - 238
    05/01/2011 Authors: Capuron L; Miller AH
  • A Prospective Study of Cancer-related Fatigue in Women Undergoing Radiotherapy for Breast Cancer
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS Volume: 81 Page(s): S65 - S66
    01/01/2011 Authors: Torres M; Liu T; Chen H; Godette K; Stapleford L; Mister D; Castro M; Li J; Pace TW; Miller AH
  • Inflammation in depression: is adiposity a cause?
    Dialogues Clin Neurosci Volume: 13 Page(s): 41 - 53
    01/01/2011 Authors: Shelton RC; Miller AH
  • Chronic interferon-alpha administration disrupts sleep continuity and depth in patients with hepatitis C: association with fatigue, motor slowing, and increased evening cortisol.
    Biol Psychiatry Volume: 68 Page(s): 942 - 949
    11/15/2010 Authors: Raison CL; Rye DB; Woolwine BJ; Vogt GJ; Bautista BM; Spivey JR; Miller AH
  • Eating ourselves to death (and despair): the contribution of adiposity and inflammation to depression.
    Prog Neurobiol Volume: 91 Page(s): 275 - 299
    08/01/2010 Authors: Shelton RC; Miller AH
  • Interleukin-1 mediates long-term hippocampal dentate granule cell loss following postnatal viral infection.
    J Mol Neurosci Volume: 41 Page(s): 89 - 96
    05/01/2010 Authors: Orr AG; Sharma A; Binder NB; Miller AH; Pearce BD
  • Interferon-Alpha Treatment In Rhesus Macque; The Behavioral, Biochemical and Hematological Effects of Four Weeks of Daily Treatments
    Volume: 67 Page(s): 123S - 123S
    05/01/2010 Authors: Cummins AC; Chisholm K; Delaney D; Noble PL; Johnson E; Miller AH; Winslow JT
  • Interferon-alpha effects on diurnal hypothalamic-pituitary-adrenal axis activity: relationship with proinflammatory cytokines and behavior.
    Mol Psychiatry Volume: 15 Page(s): 535 - 547
    05/01/2010 Authors: Raison CL; Borisov AS; Woolwine BJ; Massung B; Vogt G; Miller AH
  • CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression.
    Mol Psychiatry Volume: 15 Page(s): 393 - 403
    04/01/2010 Authors: Raison CL; Dantzer R; Kelley KW; Lawson MA; Woolwine BJ; Vogt G; Spivey JR; Saito K; Miller AH
  • Depression and immunity: a role for T cells?
    Brain Behav Immun Volume: 24 Page(s): 1 - 8
    01/01/2010 Authors: Miller AH
  • Serotonin transporter gene, depressive symptoms, and interleukin-6.
    Circ Cardiovasc Genet Volume: 2 Page(s): 614 - 620
    12/01/2009 Authors: Su S; Zhao J; Bremner JD; Miller AH; Tang W; Bouzyk M; Snieder H; Novik O; Afzal N; Goldberg J
  • Does cytokine-induced depression differ from idiopathic major depression in medically healthy individuals?
    J Affect Disord Volume: 119 Page(s): 181 - 185
    12/01/2009 Authors: Capuron L; Fornwalt FB; Knight BT; Harvey PD; Ninan PT; Miller AH
  • Functional polymorphisms in the interleukin-6 and serotonin transporter genes, and depression and fatigue induced by interferon-alpha and ribavirin treatment.
    Mol Psychiatry Volume: 14 Page(s): 1095 - 1104
    12/01/2009 Authors: Bull SJ; Huezo-Diaz P; Binder EB; Cubells JF; Ranjith G; Maddock C; Miyazaki C; Alexander N; Hotopf M; Cleare AJ
  • Lower CSF oxytocin concentrations in women with a history of childhood abuse.
    Mol Psychiatry Volume: 14 Page(s): 954 - 958
    10/01/2009 Authors: Heim C; Young LJ; Newport DJ; Mletzko T; Miller AH; Nemeroff CB
  • Sequential multiple-assignment randomized trial design of neurobehavioral treatment for patients with metastatic malignant melanoma undergoing high-dose interferon-alpha therapy.
    Clin Trials Volume: 6 Page(s): 480 - 490
    10/01/2009 Authors: Auyeung SF; Long Q; Royster EB; Murthy S; McNutt MD; Lawson D; Miller A; Manatunga A; Musselman DL
  • Cytokines and glucocorticoid receptor signaling. Relevance to major depression.
    Ann N Y Acad Sci Volume: 1179 Page(s): 86 - 105
    10/01/2009 Authors: Pace TWW; Miller AH
  • ALTERED SALIVARY ALPHA-AMYLASE ACTIVITY UNDER BASAL AND STIMULATED CONDITIONS IN CHRONIC FATIGUE SYNDROME
    Volume: 46 Page(s): S14 - S14
    09/01/2009 Authors: Nater UM; Miller AH; Jones JF; Reeves WC
  • Interferon-alpha inhibits glucocorticoid receptor-mediated gene transcription via STAT5 activation in mouse HT22 cells.
    Brain Behav Immun Volume: 23 Page(s): 455 - 463
    05/01/2009 Authors: Hu F; Pace TWW; Miller AH
  • Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression.
    Biol Psychiatry Volume: 65 Page(s): 732 - 741
    05/01/2009 Authors: Miller AH; Maletic V; Raison CL
  • Activation of Neuroendocrine Pathways by IL-2 Administration in Patients with Malignant Melanoma
    Volume: 65 Page(s): 67S - 67S
    04/15/2009 Authors: Royster EB; Graciaa DS; Trimble LM; Miller AH; Musselman DL
  • Cytokine-Induced Activation of IDO Pathways in the Brain: Relevance to Glia-Neuron Interactions and Depression
    Volume: 65 Page(s): 181S - 181S
    04/15/2009 Authors: Miller AH
  • Haplotypes of Serotonin Transporter Gene Associated with Both Depressive Symptoms and Interleukin-6 in Middle-Aged Males: The Twins Heart Study
    Volume: 119 Page(s): E282 - E282
    03/17/2009 Authors: Su S; Zhao J; Bremner JD; Miller AH; Bouzyk M; Snieder H; Goldberg J; Vaccarino V
  • Activation of central nervous system inflammatory pathways by interferon-alpha: relationship to monoamines and depression.
    Biol Psychiatry Volume: 65 Page(s): 296 - 303
    02/15/2009 Authors: Raison CL; Borisov AS; Majer M; Drake DF; Pagnoni G; Woolwine BJ; Vogt GJ; Massung B; Miller AH
  • Common genetic contributions to depressive symptoms and inflammatory markers in middle-aged men: the Twins Heart Study.
    Psychosom Med Volume: 71 Page(s): 152 - 158
    02/01/2009 Authors: Su S; Miller AH; Snieder H; Bremner JD; Ritchie J; Maisano C; Jones L; Murrah NV; Goldberg J; Vaccarino V
  • Norman Cousins Lecture. Mechanisms of cytokine-induced behavioral changes: psychoneuroimmunology at the translational interface.
    Brain Behav Immun Volume: 23 Page(s): 149 - 158
    02/01/2009 Authors: Miller AH
  • Brain-Immune System Interactions Relevance to the Pathophysiology and Treatment of Neuropsychiatric Disorders
    Page(s): 201 - 220
    01/01/2009 Authors: Raison CL; Cowles MK; Miller AH
  • Depressive symptoms and metabolic syndrome: is inflammation the underlying link?
    Biol Psychiatry Volume: 64 Page(s): 896 - 900
    11/15/2008 Authors: Capuron L; Su S; Miller AH; Bremner JD; Goldberg J; Vogt GJ; Maisano C; Jones L; Murrah NV; Vaccarino V
  • Association of major depressive disorder with serum myeloperoxidase and other markers of inflammation: a twin study.
    Biol Psychiatry Volume: 64 Page(s): 476 - 483
    09/15/2008 Authors: Vaccarino V; Brennan M-L; Miller AH; Bremner JD; Ritchie JC; Lindau F; Veledar E; Su S; Murrah NV; Jones L
  • Neuropsychological performance in persons with chronic fatigue syndrome: results from a population-based study.
    Psychosom Med Volume: 70 Page(s): 829 - 836
    09/01/2008 Authors: Majer M; Welberg LAM; Capuron L; Miller AH; Pagnoni G; Reeves WC
  • Inflammation versus glucocorticoids as purveyors of pathology during stress: have we reached the tipping point?
    Biol Psychiatry Volume: 64 Page(s): 263 - 265
    08/15/2008 Authors: Miller AH
  • IFN-alpha-induced motor slowing is associated with increased depression and fatigue in patients with chronic hepatitis C.
    Brain Behav Immun Volume: 22 Page(s): 870 - 880
    08/01/2008 Authors: Majer M; Welberg LAM; Capuron L; Pagnoni G; Raison CL; Miller AH
  • The link between childhood trauma and depression: insights from HPA axis studies in humans.
    Psychoneuroendocrinology Volume: 33 Page(s): 693 - 710
    07/01/2008 Authors: Heim C; Newport DJ; Mletzko T; Miller AH; Nemeroff CB
  • Synthesis, fluorine-18 radiolabeling, and in vitro characterization of 1-iodophenyl-N-methyl-N-fluoroalkyl-3-isoquinoline carboxamide derivatives as potential PET radioligands for imaging peripheral benzodiazepine receptor.
    Bioorg Med Chem Volume: 16 Page(s): 6145 - 6155
    06/01/2008 Authors: Yu W; Wang E; Voll RJ; Miller AH; Goodman MM
  • Alterations in diurnal salivary cortisol rhythm in a population-based sample of cases with chronic fatigue syndrome.
    Psychosom Med Volume: 70 Page(s): 298 - 305
    04/01/2008 Authors: Nater UM; Youngblood LS; Jones JF; Unger ER; Miller AH; Reeves WC; Heim C
  • Cytokines and psychopathology: Lessons from interferon-alpha
    Volume: 63 Page(s): 160S - 160S
    04/01/2008 Authors: Miller AH
  • Neuroendocrine-immune mechanisms of behavioral comorbidities in patients with cancer.
    J Clin Oncol Volume: 26 Page(s): 971 - 982
    02/20/2008 Authors: Miller AH; Ancoli-Israel S; Bower JE; Capuron L; Irwin MR
  • Pro-inflammatory cytokine-induced SAPK/MAPK and JAK/STAT in rheumatoid arthritis and the new anti-depression drugs.
    Expert Opin Ther Targets Volume: 12 Page(s): 171 - 183
    02/01/2008 Authors: Malemud CJ; Miller AH
  • Anti-inflammatory effects of LJP 1586 [Z-3-fluoro-2-(4-methoxybenzyl)allylamine hydrochloride], an amine-based inhibitor of semicarbazide-sensitive amine oxidase activity.
    J Pharmacol Exp Ther Volume: 324 Page(s): 867 - 875
    02/01/2008 Authors: O'Rourke AM; Wang EY; Miller A; Podar EM; Scheyhing K; Huang L; Kessler C; Gao H; Ton-Nu H-T; Macdonald MT
  • Adherence to the mediterranean diet is inversely associated with circulating interleukin-6 among middle-aged men: a twin study.
    Circulation Volume: 117 Page(s): 169 - 175
    01/15/2008 Authors: Dai J; Miller AH; Bremner JD; Goldberg J; Jones L; Shallenberger L; Buckham R; Murrah NV; Veledar E; Wilson PW
  • Synthesis and in vitro evaluation of PK11195 analogue 1-(2-iodophenyl)-N-methyl-N-[F-18]fluoropropyl-3-isoquinoline carboxamide as a potential peripheral benzodiazepine receptor radioligand
    Volume: 41 Page(s): T105 - T105
    01/01/2008 Authors: Yu W; Voll RJ; Miller AH; Goodman MM
  • Identification and treatment of symptoms associated with inflammation in medically ill patients.
    Psychoneuroendocrinology Volume: 33 Page(s): 18 - 29
    01/01/2008 Authors: Dantzer R; Capuron L; Irwin MR; Miller AH; Ollat H; Perry VH; Rousey S; Yirmiya R
  • Elucidating the consequences of chronic stress on immune regulation and behavior in rheumatoid arthritis.
    Brain Behav Immun Volume: 22 Page(s): 22 - 23
    01/01/2008 Authors: Miller AH
  • Effects of interferon-alpha on rhesus monkeys: a nonhuman primate model of cytokine-induced depression.
    Biol Psychiatry Volume: 62 Page(s): 1324 - 1333
    12/01/2007 Authors: Felger JC; Alagbe O; Hu F; Mook D; Freeman AA; Sanchez MM; Kalin NH; Ratti E; Nemeroff CB; Miller AH
  • Basal ganglia hypermetabolism and symptoms of fatigue during interferon-alpha therapy.
    Neuropsychopharmacology Volume: 32 Page(s): 2384 - 2392
    11/01/2007 Authors: Capuron L; Pagnoni G; Demetrashvili MF; Lawson DH; Fornwalt FB; Woolwine B; Berns GS; Nemeroff CB; Miller AH
  • Letter to the Editor Re: "an inflammatory review of glucocorticoids in the CNS" by Sorrells et al. Brain, Behavior and Immunity 21, 259-272, 2007.
    Brain Behav Immun Volume: 21 Page(s): 988 - 989
    10/01/2007 Authors: Miller AH
  • Activated p38 MAPK is associated with decreased CSF 5-HIAA and increased maternal rejection during infancy in rhesus monkeys.
    Mol Psychiatry Volume: 12 Page(s): 895 - 897
    10/01/2007 Authors: Sanchez MM; Alagbe O; Felger JC; Zhang J; Graff AE; Grand AP; Maestripieri D; Miller AH
  • Depressive disorders and immunity: 20 years of progress and discovery.
    Brain Behav Immun Volume: 21 Page(s): 374 - 383
    05/01/2007 Authors: Irwin MR; Miller AH
  • Endogenous glucocorticoids protect against TNF-alpha-induced increases in anxiety-like behavior in virally infected mice.
    Mol Psychiatry Volume: 12 Page(s): 408 - 417
    04/01/2007 Authors: Silverman MN; Macdougall MG; Hu F; Pace TWW; Raison CL; Miller AH
  • Common genetic and environmental contributions to depression and inflammatory markers in middle-aged men: The twins heart study
    Volume: 115 Page(s): E216 - E216
    02/27/2007 Authors: Su S; Miller AH; Snieder H; Lee F; Bremner JD; Ritchie J; Maisano C; Buckham R; Jones L; Murrah N
  • Shared environmental and genetic effects do not confound the association between the mediterranean diet and inflammation
    Volume: 115 Page(s): E218 - E218
    02/27/2007 Authors: Dai J; Miller AH; Bremner JD; Goldberg J; Jones L; Buckham R; Murrah N; Veledar E; Vaccarino LV
  • Benefit of inhibiting SSAO in relapsing experimental autoimmune encephalomyelitis.
    Volume: 114 Page(s): 845 - 849
    01/01/2007 Authors: O'Rourke AM; Wang EY; Salter-Cid L; Huang L; Miller A; Podar E; Gao HF; Jones DS; Linnik MD
  • Cytokine-effects on glucocorticoid receptor function: relevance to glucocorticoid resistance and the pathophysiology and treatment of major depression.
    Brain Behav Immun Volume: 21 Page(s): 9 - 19
    01/01/2007 Authors: Pace TWW; Hu F; Miller AH
  • Adherence to the mediterranean diet decreases systemic IL-6 among middle-aged monozygotic male twins free of symptomatic cardiovascular diseases
    Volume: 114 Page(s): 883 - 883
    10/31/2006 Authors: Dal J; Miller AH; Bremner D; Goldberg J; Jones L; Foster J; Buckham R; Murrah N; Vaccarino V
  • Decreased heart rate variability, a measure of autonomic dysfunction, is associated with higher levels of inflammation as measured by IL-6
    Volume: 114 Page(s): 471 - 471
    10/31/2006 Authors: Lampert RJ; Bremner JD; Su S; Miller AH; Lee FA; Cheema F; Goldberg J; Vaccarino V
  • Genetic and environmental influences on inflammatory markers: A study of middle-aged male twins
    Volume: 114 Page(s): 839 - 839
    10/31/2006 Authors: Su S; Snieder H; Miller AH; Ritchie J; Bremner JD; Goldberg J; Maisano C; Jones L; Murrah N; Zhao J
  • On redefining the role of the immune system in psychiatric disease.
    Biol Psychiatry Volume: 60 Page(s): 796 - 798
    10/15/2006 Authors: Miller AH; Manji HK
  • Cytokines, p38 MAP kinase and the pathophysiology of depression.
    Neuropsychopharmacology Volume: 31 Page(s): 2089 - 2090
    10/01/2006 Authors: Miller AH; Raison CL
  • Efficacy of risperidone versus olanzapine in patients with schizophrenia previously on chronic conventional antipsychotic therapy: a switch study.
    J Psychiatr Res Volume: 40 Page(s): 669 - 676
    10/01/2006 Authors: Wang X; Savage R; Borisov A; Rosenberg J; Woolwine B; Tucker M; May R; Feldman J; Nemeroff CB; Miller AH
  • Increased stress-induced inflammatory responses in male patients with major depression and increased early life stress.
    Am J Psychiatry Volume: 163 Page(s): 1630 - 1633
    09/01/2006 Authors: Pace TWW; Mletzko TC; Alagbe O; Musselman DL; Nemeroff CB; Miller AH; Heim CM
  • Cognitive dysfunction relates to subjective report of mental fatigue in patients with chronic fatigue syndrome.
    Neuropsychopharmacology Volume: 31 Page(s): 1777 - 1784
    08/01/2006 Authors: Capuron L; Welberg L; Heim C; Wagner D; Solomon L; Papanicolaou DA; Craddock RC; Miller AH; Reeves WC
  • Stress, inflammatory signalling and glucocorticoid receptor function: Role in affective disorders
    Volume: 9 Page(s): S72 - S72
    07/01/2006 Authors: Miller AH
  • Inflammation and the brain: Role of innate immune responses in the development and treatment of major depression
    Volume: 9 Page(s): S32 - S32
    07/01/2006 Authors: Miller AH
  • Design, synthesis, and biological evaluation of semicarbazide-sensitive amine oxidase (SSAO) inhibitors with anti-inflammatory activity.
    J Med Chem Volume: 49 Page(s): 2166 - 2173
    04/06/2006 Authors: Wang EY; Gao H; Salter-Cid L; Zhang J; Huang L; Podar EM; Miller A; Zhao J; O'rourke A; Linnik MD
  • Cytokines sing the blues: inflammation and the pathogenesis of depression.
    Trends Immunol Volume: 27 Page(s): 24 - 31
    01/01/2006 Authors: Raison CL; Capuron L; Miller AH
  • Brain systems regulating the organism's response to stress: Preclinical and clinical studies
    Volume: 30 Page(s): S19 - S19
    12/01/2005 Authors: Nemeroff CB; Heim C; Musselman DL; Miller AH
  • The association of fatigue with poor virologic response in patients receiving interferon-alpha plus ribavirin for the treatment of hepatitis C
    Volume: 30 Page(s): S140 - S140
    12/01/2005 Authors: Raison CL; Pariante CM; Capuron L; Chen B; Woolwine BJ; Plotsky PM; Jacobson IM; Miller AH
  • Increased basal ganglia activity during interferon-alpha therapy for malignant melanoma: Relationship with neurovegetative symptoms
    Volume: 30 Page(s): S222 - S223
    12/01/2005 Authors: Capuron L; Pagnoni G; Demitrashvili M; Lawson DH; Berns GS; Nemeroff CB; Miller AH
  • Changes in natural killer cell function, inflammatory signaling and plasma IL-6 production during acute stress in patients with major depression
    Volume: 30 Page(s): S264 - S264
    12/01/2005 Authors: Alagbe O; Pace T; Mletzko T; Vogt J; Nemeroff C; Heim C; Miller A
  • Anti-inflammatory effects of inhibiting the amine oxidase activity of semicarbazide-sensitive amine oxidase.
    J Pharmacol Exp Ther Volume: 315 Page(s): 553 - 562
    11/01/2005 Authors: Salter-Cid LM; Wang E; O'Rourke AM; Miller A; Gao H; Huang L; Garcia A; Linnik MD
  • The association of fatigue with poor virologic response in patients receiving interferon-alpha plus ribavirin for the treatment of hepatitis C
    Volume: 42 Page(s): 676A - 676A
    10/01/2005 Authors: Raison CL; Pariante CM; Capuron L; Chen B; Woolwine BJ; Bruno C; Jacobson I; Miller AH
  • Mood disorders in the medically ill: scientific review and recommendations.
    Biol Psychiatry Volume: 58 Page(s): 175 - 189
    08/01/2005 Authors: Evans DL; Charney DS; Lewis L; Golden RN; Gorman JM; Krishnan KRR; Nemeroff CB; Bremner JD; Carney RM; Coyne JC
  • Anterior cingulate activation and error processing during interferon-alpha treatment.
    Biol Psychiatry Volume: 58 Page(s): 190 - 196
    08/01/2005 Authors: Capuron L; Pagnoni G; Demetrashvili M; Woolwine BJ; Nemeroff CB; Berns GS; Miller AH
  • Depressive symptoms and viral clearance: In response
    BRAIN BEHAVIOR AND IMMUNITY Volume: 19 Page(s): 273 - 274
    07/01/2005 Authors: Raison CL; Capuron L; Miller AH
  • The association between viral clearance and depression in patients with hepatitis C receiving interferon-alpha and ribavirin.
    Brain Behav Immun Volume: 19 Page(s): 271 - 272
    07/01/2005 Authors: Loftis JM; Hauser P; Rifai MA
  • Inhibition of COX-2 by celecoxib enhances glucocorticoid receptor function.
    Mol Psychiatry Volume: 10 Page(s): 426 - 428
    05/01/2005 Authors: Hu F; Wang X; Pace TWW; Wu H; Miller AH
  • Molecular mechanisms linking inflammation and the HPA axis in the pathogenesis of depression
    Volume: 57 Page(s): 156S - 156S
    04/15/2005 Authors: Miller AH
  • Inhibition of Jun N-terminal kinase (JNK) enhances glucocorticoid receptor-mediated function in mouse hippocampal HT22 cells.
    Neuropsychopharmacology Volume: 30 Page(s): 242 - 249
    02/01/2005 Authors: Wang X; Wu H; Lakdawala VS; Hu F; Hanson ND; Miller AH
  • Promoter polymorphisms of the interferon-alpha receptor gene and development of Interferon-induced depressive symptoms in patients with chronic hepatitis C: preliminary findings.
    Neuropsychobiology Volume: 52 Page(s): 55 - 61
    01/01/2005 Authors: Yoshida K; Alagbe O; Wang X; Woolwine B; Thornbury M; Raison CL; Miller AH
  • Depressive symptoms and viral clearance in patients receiving interferon-alpha and ribavirin for hepatitis C.
    Brain Behav Immun Volume: 19 Page(s): 23 - 27
    01/01/2005 Authors: Raison CL; Broadwell SD; Borisov AS; Manatunga AK; Capuron L; Woolwine BJ; Jacobson IM; Nemeroff CB; Miller AH
  • Interferon-alpha treatment of patients with hepatitis C - The role of a comprehensive risk-benefit assessment - The authors' reply
    CNS DRUGS Volume: 19 Page(s): 721 - 722
    01/01/2005 Authors: Raison CL; Demetrashvili M; Capuron L; Miller AH
  • Immune modulation of the hypothalamic-pituitary-adrenal (HPA) axis during viral infection.
    Viral Immunol Volume: 18 Page(s): 41 - 78
    01/01/2005 Authors: Silverman MN; Pearce BD; Biron CA; Miller AH
  • Interferon-alpha treatment of patients with Hepatitis C: the role of a comprehensive risk-benefit assessment.
    CNS Drugs Volume: 19 Page(s): 719 - 721
    01/01/2005 Authors: Rifai MA; Loftis JM; Hauser P
  • Depression during pegylated interferon-alpha plus ribavirin therapy: prevalence and prediction.
    J Clin Psychiatry Volume: 66 Page(s): 41 - 48
    01/01/2005 Authors: Raison CL; Borisov AS; Broadwell SD; Capuron L; Woolwine BJ; Jacobson IM; Nemeroff CB; Miller AH
  • Neuropsychiatric adverse effects of interferon-alpha: recognition and management.
    CNS Drugs Volume: 19 Page(s): 105 - 123
    01/01/2005 Authors: Raison CL; Demetrashvili M; Capuron L; Miller AH
  • Probing inflammatory signaling pathways in IFN-alpha-treated, HIV/HCV co-infected patients using flow cytometry
    Volume: 29 Page(s): S86 - S87
    12/01/2004 Authors: Alagbe O; Wang XH; Miller AH
  • Syndrome of chronic fatigue in patients receiving interferon-alpha for chronic hepatitis C
    Volume: 29 Page(s): S234 - S235
    12/01/2004 Authors: Raison CL; Borisov AS; Broadwell SD; Capuron L; Woolwine BJ; Nemeroff CB; Miller AH
  • Switching schizophrenia patients previously stable on chronic conventional antipsychotic therapy to risperidone versus olanzapine
    Volume: 29 Page(s): S175 - S175
    12/01/2004 Authors: Wang XH; Savage R; Borisov A; Rosenberg J; Woolwine B; Peelor M; May R; Feldman J; Miller AH
  • Cytokines and psychopathology: lessons from interferon-alpha.
    Biol Psychiatry Volume: 56 Page(s): 819 - 824
    12/01/2004 Authors: Capuron L; Miller AH
  • Characterization of an interleukin-6- and adrenocorticotropin-dependent, immune-to-adrenal pathway during viral infection.
    Endocrinology Volume: 145 Page(s): 3580 - 3589
    08/01/2004 Authors: Silverman MN; Miller AH; Biron CA; Pearce BD
  • Early life stress and PTSD symptoms in patients with comorbid schizophrenia and substance abuse.
    Schizophr Res Volume: 69 Page(s): 167 - 174
    08/01/2004 Authors: Scheller-Gilkey G; Moynes K; Cooper I; Kant C; Miller AH
  • Breast cancer and depression.
    Oncology (Williston Park) Volume: 18 Page(s): 1021 - 1034
    07/01/2004 Authors: Somerset W; Stout SC; Miller AH; Musselman D
  • Fronto-parietal recruitment enables interferon-alpha treated patients to maintain normal performance on a task of visuo-spatial attention
    Volume: 7 Page(s): S474 - S474
    06/01/2004 Authors: Capuron L; Pagnoni G; Demetrashvili M; Nemeroff CB; Berns GS; Miller AH
  • Plasma homocysteine and immune activation in patients with malignant melanoma undergoing treatment with IFN-alpha.
    J Interferon Cytokine Res Volume: 24 Page(s): 311 - 317
    05/01/2004 Authors: Frick B; Capuron L; Schrcksnadel K; Musselman DL; Lawson DH; Nemeroff CB; Miller AH; Fuchs D
  • Baseline mood and psychosocial characteristics of patients developing depressive symptoms during interleukin-2 and/or interferon-alpha cancer therapy.
    Brain Behav Immun Volume: 18 Page(s): 205 - 213
    05/01/2004 Authors: Capuron L; Ravaud A; Miller AH; Dantzer R
  • Ribavirin may be an important factor in IFN-induced neuropsychiatric effects.
    J Clin Psychiatry Volume: 65 Page(s): 581
    04/01/2004 Authors: Asnis GM; De La Garza R; Miller AH; Raison CL
  • HPA axis responses and the development of cytokine-induced depression
    JOURNAL OF AFFECTIVE DISORDERS Volume: 78 Page(s): S52 - S52
    03/01/2004 Authors: Miller A
  • Pituitary-adrenal responses to standard and low-dose dexamethasone suppression tests in adult survivors of child abuse.
    Biol Psychiatry Volume: 55 Page(s): 10 - 20
    01/01/2004 Authors: Newport DJ; Heim C; Bonsall R; Miller AH; Nemeroff CB
  • Interleukin 1alpha (IL-1alpha) induced activation of p38 mitogen-activated protein kinase inhibits glucocorticoid receptor function.
    Mol Psychiatry Volume: 9 Page(s): 65 - 75
    01/01/2004 Authors: Wang X; Wu H; Miller AH
  • A cytokine-based neuroimmunologic mechanism of cancer-related symptoms.
    Neuroimmunomodulation Volume: 11 Page(s): 279 - 292
    01/01/2004 Authors: Lee B-N; Dantzer R; Langley KE; Bennett GJ; Dougherty PM; Dunn AJ; Meyers CA; Miller AH; Payne R; Reuben JM
  • Interferon-alpha-induced changes in tryptophan metabolism. relationship to depression and paroxetine treatment.
    Biol Psychiatry Volume: 54 Page(s): 906 - 914
    11/01/2003 Authors: Capuron L; Neurauter G; Musselman DL; Lawson DH; Nemeroff CB; Fuchs D; Miller AH
  • Depressive symptoms during IFN-alpha/ribavirin therapy are associated with reduced viral clearance in patients with hepatitis C.
    Volume: 38 Page(s): 325A - 325A
    10/01/2003 Authors: Raison CL; Broadwell SD; Borisov AS; Manatunga AK; Woolwine BJ; Jacobson IR; Nemeroff CB; Miller AH
  • Depression during IFN-alfa plus ribavirin therapy: Prevalence and prediction.
    Volume: 38 Page(s): 326A - 326A
    10/01/2003 Authors: Raison CL; Borisov AS; Broadwell SD; Manatunga AK; Woolwine BJ; Jacobson IM; Nemeroff CB; Miller AH
  • When not enough is too much: the role of insufficient glucocorticoid signaling in the pathophysiology of stress-related disorders.
    Am J Psychiatry Volume: 160 Page(s): 1554 - 1565
    09/01/2003 Authors: Raison CL; Miller AH
  • Relationship of clinical symptoms and substance use in schizophrenia patients on conventional versus atypical antipsychotics.
    Am J Drug Alcohol Abuse Volume: 29 Page(s): 553 - 566
    08/01/2003 Authors: Scheller-Gilkey G; Woolwine BJ; Cooper I; Gay O; Moynes KA; Miller AH
  • Depression in cancer: new developments regarding diagnosis and treatment.
    Biol Psychiatry Volume: 54 Page(s): 283 - 294
    08/01/2003 Authors: Raison CL; Miller AH
  • Association of exaggerated HPA axis response to the initial injection of interferon-alpha with development of depression during interferon-alpha therapy.
    Am J Psychiatry Volume: 160 Page(s): 1342 - 1345
    07/01/2003 Authors: Capuron L; Raison CL; Musselman DL; Lawson DH; Nemeroff CB; Miller AH
  • Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? A cytokine-immunologic model of cancer symptoms.
    Cancer Volume: 97 Page(s): 2919 - 2925
    06/01/2003 Authors: Cleeland CS; Bennett GJ; Dantzer R; Dougherty PM; Dunn AJ; Meyers CA; Miller AH; Payne R; Reuben JM; Wang XS
  • Cerebrospinal fluid corticotropin-releasing factor (CRF) and vasopressin concentrations predict pituitary response in the CRF stimulation test: a multiple regression analysis.
    Neuropsychopharmacology Volume: 28 Page(s): 569 - 576
    03/01/2003 Authors: Newport DJ; Heim C; Owens MJ; Ritchie JC; Ramsey CH; Bonsall R; Miller AH; Nemeroff CB
  • Cytokines and sickness behavior: implications for cancer care and control.
    Brain Behav Immun Volume: 17 Suppl 1 Page(s): S132 - S134
    02/01/2003 Authors: Miller AH
  • Paroxetine use in medically ill patients.
    Psychopharmacol Bull Volume: 37 Suppl 1 Page(s): 108 - 122
    01/01/2003 Authors: Stout SS; Somerset WI; Miller A; Musselman DL
  • [Neuro-immune interactions in psychopathology with the example of interferon-alpha-induced depression].
    J Soc Biol Volume: 197 Page(s): 151 - 156
    01/01/2003 Authors: Capuron L; Dantzer R; Miller AH
  • Antidepressant treatment of cytokine-induced mood disorders.
    Acta Neuropsychiatr Volume: 14 Page(s): 336 - 343
    12/01/2002 Authors: Raison CL; Marcin M; Miller AH
  • Childhood trauma associated with smaller hippocampal volume in women with major depression.
    Am J Psychiatry Volume: 159 Page(s): 2072 - 2080
    12/01/2002 Authors: Vythilingam M; Heim C; Newport J; Miller AH; Anderson E; Bronen R; Brummer M; Staib L; Vermetten E; Charney DS
  • The phosphodiesterase type 4 inhibitor, rolipram, enhances glucocorticoid receptor function.
    Neuropsychopharmacology Volume: 27 Page(s): 939 - 948
    12/01/2002 Authors: Miller AH; Vogt GJ; Pearce BD
  • Neonatal viral infection decreases neuronal progenitors and impairs adult neurogenesis in the hippocampus.
    Neurobiol Dis Volume: 11 Page(s): 246 - 256
    11/01/2002 Authors: Sharma A; Valadi N; Miller AH; Pearce BD
  • Treatment of cytokine-induced depression.
    Brain Behav Immun Volume: 16 Page(s): 575 - 580
    10/01/2002 Authors: Capuron L; Hauser P; Hinze-Selch D; Miller AH; Neveu PJ
  • Psychoneuroimmunology: Stress, mental disorders and health
    PSYCHOSOMATIC MEDICINE Volume: 64 Page(s): 847 - 848
    09/01/2002 Authors: Raison CL; Miller AH
  • Fundamentals of psychoneuroimmunology
    PSYCHOSOMATIC MEDICINE Volume: 64 Page(s): 848 - 849
    09/01/2002 Authors: Capuron L; Gumnick JF; Miller AH
  • Current management of depression in cancer patients - The Schwartz/Lander/Chochinov article reviewed
    ONCOLOGY-NEW YORK Volume: 16 Page(s): 1110 - +
    08/01/2002 Authors: Musselman DL; Lawson D; Miller AH
  • Psychoneuroimmunology
    PSYCHOSOMATIC MEDICINE Volume: 64 Page(s): 692 - 693
    07/01/2002 Authors: Raison CL; Miller AH
  • Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions.
    Neuropsychopharmacology Volume: 26 Page(s): 643 - 652
    05/01/2002 Authors: Capuron L; Gumnick JF; Musselman DL; Lawson DH; Reemsnyder A; Nemeroff CB; Miller AH
  • Increased early life stress and depressive symptoms in patients with comorbid substance abuse and schizophrenia.
    Schizophr Bull Volume: 28 Page(s): 223 - 231
    01/01/2002 Authors: Scheller-Gilkey G; Thomas SM; Woolwine BJ; Miller AH
  • Antipsychotic-induced hyperprolactinemia and sexual dysfunction.
    Psychopharmacol Bull Volume: 36 Page(s): 143 - 164
    01/01/2002 Authors: Compton MT; Miller AH
  • The role of early adverse experience and adulthood stress in the prediction of neuroendocrine stress reactivity in women: a multiple regression analysis.
    Depress Anxiety Volume: 15 Page(s): 117 - 125
    01/01/2002 Authors: Heim C; Newport DJ; Wagner D; Wilcox MM; Miller AH; Nemeroff CB
  • Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy.
    Mol Psychiatry Volume: 7 Page(s): 468 - 473
    01/01/2002 Authors: Capuron L; Ravaud A; Neveu PJ; Miller AH; Maes M; Dantzer R
  • The selective serotonin reuptake inhibitor paroxetine is effective in more generalized and in less generalized social anxiety disorder.
    Psychopharmacology (Berl) Volume: 158 Page(s): 267 - 272
    11/01/2001 Authors: Stein DJ; Stein MB; Goodwin W; Kumar R; Hunter B
  • Antidepressants enhance glucocorticoid receptor function in vitro by modulating the membrane steroid transporters.
    Br J Pharmacol Volume: 134 Page(s): 1335 - 1343
    11/01/2001 Authors: Pariante CM; Makoff A; Lovestone S; Feroli S; Heyden A; Miller AH; Kerwin RW
  • The neuroimmunology of stress and depression.
    Semin Clin Neuropsychiatry Volume: 6 Page(s): 277 - 294
    10/01/2001 Authors: Raison CL; Miller AH
  • Paroxetine for the prevention of depression induced by interferon alfa.
    N Engl J Med Volume: 345 Page(s): 375 - 376
    08/02/2001 Authors: Kraus MR; Schfer A; Scheurlen M
  • Paroxetine for the prevention of depression induced by interferon alfa - Reply
    NEW ENGLAND JOURNAL OF MEDICINE Volume: 345 Page(s): 376 - 376
    08/02/2001 Authors: Miller AH; Musselman DL; Nemeroff CB
  • Higher than normal plasma interleukin-6 concentrations in cancer patients with depression: preliminary findings.
    Am J Psychiatry Volume: 158 Page(s): 1252 - 1257
    08/01/2001 Authors: Musselman DL; Miller AH; Porter MR; Manatunga A; Gao F; Penna S; Pearce BD; Landry J; Glover S; McDaniel JS
  • Priapism associated with conventional and atypical antipsychotic medications: a review.
    J Clin Psychiatry Volume: 62 Page(s): 362 - 366
    05/01/2001 Authors: Compton MT; Miller AH
  • The steroid receptor antagonists RU40555 and RU486 activate glucocorticoid receptor translocation and are not excreted by the steroid hormones transporter in L929 cells.
    J Endocrinol Volume: 169 Page(s): 309 - 320
    05/01/2001 Authors: Pariante CM; Pearce BD; Pisell TL; Su C; Miller AH
  • Use of atypical antipsychotics in schizophrenia patients with a history of substance abuse
    SCHIZOPHRENIA RESEARCH Volume: 49 Page(s): 244 - 244
    04/15/2001 Authors: Scheller-Gilkey G; Woolwine BJ; Moynes KA; Kant CA; Robinson IC; Gay O; Miller AH
  • Altered pituitary-adrenal axis responses to provocative challenge tests in adult survivors of childhood abuse.
    Am J Psychiatry Volume: 158 Page(s): 575 - 581
    04/01/2001 Authors: Heim C; Newport DJ; Bonsall R; Miller AH; Nemeroff CB
  • Paroxetine for the prevention of depression induced by high-dose interferon alfa.
    N Engl J Med Volume: 344 Page(s): 961 - 966
    03/29/2001 Authors: Musselman DL; Lawson DH; Gumnick JF; Manatunga AK; Penna S; Goodkin RS; Greiner K; Nemeroff CB; Miller AH
  • Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment.
    Biol Psychiatry Volume: 49 Page(s): 391 - 404
    03/01/2001 Authors: Pariante CM; Miller AH
  • Sexual side effects associated with conventional and atypical antipsychotics.
    Psychopharmacol Bull Volume: 35 Page(s): 89 - 108
    01/01/2001 Authors: Compton MT; Miller AH
  • Neuroendocrine-immune interactions during viral infections.
    Adv Virus Res Volume: 56 Page(s): 469 - 513
    01/01/2001 Authors: Pearce BD; Biron CA; Miller AH
  • Pituitary-adrenal responsiveness of adult survivors of childhood abuse in the CRF stimulation test
    JOURNAL OF PSYCHOPHYSIOLOGY Volume: 15 Page(s): 130 - 130
    01/01/2001 Authors: Heim C; Newport DJ; Graham Y; Heit S; Bonsall R; Miller AH; Nemeroff CB
  • Viral infection of developing GABAergic neurons in a model of hippocampal disinhibition.
    Neuroreport Volume: 11 Page(s): 2433 - 2438
    08/03/2000 Authors: Pearce BD; Valadi NM; Po CL; Miller AH
  • Pituitary-adrenal and autonomic responses to stress in women after sexual and physical abuse in childhood.
    JAMA Volume: 284 Page(s): 592 - 597
    08/02/2000 Authors: Heim C; Newport DJ; Heit S; Graham YP; Wilcox M; Bonsall R; Miller AH; Nemeroff CB
  • Double jeopardy: schizophrenia and substance use.
    Am J Drug Alcohol Abuse Volume: 26 Page(s): 343 - 353
    08/01/2000 Authors: Swofford CD; Scheller-Gilkey G; Miller AH; Woolwine B; Mance R
  • Atypical medications in schizophrenia patients with a history of substance abuse
    SCHIZOPHRENIA RESEARCH Volume: 41 Page(s): 213 - 214
    01/03/2000 Authors: Scheller-Gilkey G; Woolwine B; Robinson I; Gay O; Miller AH
  • Types of early trauma in an urban population with schizophrenia and substance abuse
    SCHIZOPHRENIA RESEARCH Volume: 41 Page(s): 49 - 50
    01/03/2000 Authors: Woolwine BJ; Scheller-Gilkey G; Farill M; Miller AH
  • Development of a new green fluorescent protein-glucocorticoid receptor (GR) chimera to evaluate the effects of antidepressants and other steroid-independent activators of the GR
    EUROPEAN JOURNAL OF NEUROSCIENCE Volume: 12 Page(s): 415 - 415
    01/01/2000 Authors: Pariante CM; Dayanandan R; Nebbia G; Makoff A; Lovestone S; Danielsen M; Miller AH; Kerwin RW
  • Lymphocytic responses and the gradual hippocampal neuron loss following infection with lymphocytic choriomeningitis virus (LCMV).
    J Neuroimmunol Volume: 101 Page(s): 137 - 147
    11/15/1999 Authors: Pearce BD; Po CL; Pisell TL; Miller AH
  • Cerebrospinal fluid and plasma leptin measurements: covariability with dopamine and cortisol in fasting humans.
    J Clin Endocrinol Metab Volume: 84 Page(s): 3579 - 3585
    10/01/1999 Authors: Hagan MM; Havel PJ; Seeley RJ; Woods SC; Ekhator NN; Baker DG; Hill KK; Wortman MD; Miller AH; Gingerich RL
  • The proinflammatory cytokine, interleukin-1alpha, reduces glucocorticoid receptor translocation and function.
    Endocrinology Volume: 140 Page(s): 4359 - 4366
    09/01/1999 Authors: Pariante CM; Pearce BD; Pisell TL; Sanchez CI; Po C; Su C; Miller AH
  • The Proinflammatory Cytokine, Interleukin-1, Reduces Glucocorticoid Receptor Translocation and Function1.
    Endocrinology Volume: 140 Page(s): 4359 - 4366
    09/01/1999 Authors: Pariante CM; Pearce BD; Pisell TL; Sanchez CI; Po C; Su C; Miller AH
  • Paroxetine pretreatment reduces interferon-alpha-induced depression
    BIOLOGICAL PSYCHIATRY Volume: 45 Page(s): 110S - 110S
    04/15/1999 Authors: Musselman DL; Lawson DH; Penna S; Pearce BD; Su C; Nemeroff CB; Miller AH
  • Schizophrenia, substance abuse, and depression
    SCHIZOPHRENIA RESEARCH Volume: 36 Page(s): 35 - 35
    04/01/1999 Authors: Woolwine B; Scheller-Gilkey G; Miller AH
  • Endogenous glucocorticoids protect against cytokine-mediated lethality during viral infection.
    J Immunol Volume: 162 Page(s): 3527 - 3533
    03/15/1999 Authors: Ruzek MC; Pearce BD; Miller AH; Biron CA
  • Effects of cytokines on glucocorticoid receptor expression and function. Glucocorticoid resistance and relevance to depression.
    Adv Exp Med Biol Volume: 461 Page(s): 107 - 116
    01/01/1999 Authors: Miller AH; Pariante CM; Pearce BD
  • The effects of neonatal stress on brain development: implications for psychopathology.
    Dev Psychopathol Volume: 11 Page(s): 545 - 565
    01/01/1999 Authors: Graham YP; Heim C; Goodman SH; Miller AH; Nemeroff CB
  • Neuroendocrine and immune system interactions in stress and depression.
    Psychiatr Clin North Am Volume: 21 Page(s): 443 - 463
    06/01/1998 Authors: Miller AH
  • Glucocorticoid receptors are differentially expressed in the cells and tissues of the immune system.
    Cell Immunol Volume: 186 Page(s): 45 - 54
    05/25/1998 Authors: Miller AH; Spencer RL; Pearce BD; Pisell TL; Azrieli Y; Tanapat P; Moday H; Rhee R; McEwen BS
  • Relationship of seizure duration to antidepressant efficacy in electroconvulsive therapy.
    Psychol Med Volume: 27 Page(s): 1373 - 1380
    11/01/1997 Authors: Kales H; Raz J; Tandon R; Maixner D; DeQuardo J; Miller A; Becks L
  • Steroid-independent translocation of the glucocorticoid receptor by the antidepressant desipramine.
    Mol Pharmacol Volume: 52 Page(s): 571 - 581
    10/01/1997 Authors: Pariante CM; Pearce BD; Pisell TL; Owens MJ; Miller AH
  • Maintenance of Basal ACTH Levels by Corticosterone and RU28362, but not Aldosterone: Relationship to Available Type I and Type II Corticosteroid Receptor Levels in Brain and Pituitary.
    Stress Volume: 2 Page(s): 51 - 64
    10/01/1997 Authors: Spencer RL; Moday HJ; Miller AH
  • 1996 Curt P. Richter Award. Effects of viral infection on corticosterone secretion and glucocorticoid receptor binding in immune tissues.
    Psychoneuroendocrinology Volume: 22 Page(s): 455 - 474
    08/01/1997 Authors: Miller AH; Spencer RL; Pearce BD; Pisell TL; Tanapat P; Leung JJ; Dhabhar FS; McEwen BS; Biron CA
  • Characterization of early cytokine responses and an interleukin (IL)-6-dependent pathway of endogenous glucocorticoid induction during murine cytomegalovirus infection.
    J Exp Med Volume: 185 Page(s): 1185 - 1192
    04/07/1997 Authors: Ruzek MC; Miller AH; Opal SM; Pearce BD; Biron CA
  • Cytokine plasma concentrations in cancer patients with depression
    BIOLOGICAL PSYCHIATRY Volume: 41 Page(s): 97 - 97
    04/01/1997 Authors: Musselman DL; Pisell TL; Miller AH; Porter MR; Pearce BD; Knight BT; Ninan PT; Landry JL; Bonsall R; Emery M
  • Schizophrenia and substance abuse: Characteristics associated with the high rate of comorbidity
    SCHIZOPHRENIA RESEARCH Volume: 24 Page(s): 22 - 22
    03/01/1997 Authors: SchellerGilkey G; Thomas S; Chadwick N; Woolwine B; Miller A
  • The role of adrenocorticoids as modulators of immune function in health and disease: neural, endocrine and immune interactions.
    Brain Res Brain Res Rev Volume: 23 Page(s): 79 - 133
    02/01/1997 Authors: McEwen BS; Biron CA; Brunson KW; Bulloch K; Chambers WH; Dhabhar FS; Goldfarb RH; Kitson RP; Miller AH; Spencer RL
  • Chronic caregiving stress alters peripheral blood immune parameters: the role of age and severity of stress.
    Psychother Psychosom Volume: 66 Page(s): 199 - 207
    01/01/1997 Authors: Pariante CM; Carpiniello B; Orr MG; Sitzia R; Piras A; Farci AM; Del Giacco GS; Piludu G; Miller AH
  • Stress-induced changes in blood leukocyte distribution. Role of adrenal steroid hormones.
    J Immunol Volume: 157 Page(s): 1638 - 1644
    08/15/1996 Authors: Dhabhar FS; Miller AH; McEwen BS; Spencer RL
  • Chronic social stress produces reductions in available splenic type II corticosteroid receptor binding and plasma corticosteroid binding globulin levels.
    Psychoneuroendocrinology Volume: 21 Page(s): 95 - 109
    01/01/1996 Authors: Spencer RL; Miller AH; Moday H; McEwen BS; Blanchard RJ; Blanchard DC; Sakai RR
  • Glucocorticoid receptors in depression.
    Isr J Med Sci Volume: 31 Page(s): 705 - 712
    12/01/1995 Authors: Pariante CM; Nemeroff CB; Miller AH
  • Effects of stress on immune cell distribution. Dynamics and hormonal mechanisms.
    J Immunol Volume: 154 Page(s): 5511 - 5527
    05/15/1995 Authors: Dhabhar FS; Miller AH; McEwen BS; Spencer RL
  • Mechanism of interleukin 12-mediated toxicities during experimental viral infections: role of tumor necrosis factor and glucocorticoids.
    J Exp Med Volume: 181 Page(s): 901 - 914
    03/01/1995 Authors: Orange JS; Salazar-Mather TP; Opal SM; Spencer RL; Miller AH; McEwen BS; Biron CA
  • ROLE OF TNF IN IL-12-INDUCED TOXICITIES DURING VIRAL-INFECTION
    JOURNAL OF CELLULAR BIOCHEMISTRY Page(s): 286 - 286
    01/05/1995 Authors: ORANGE JS; SALAZARMATHER TP; OPAL SM; SPENCER RL; MILLER AH; MCEWEN BS; BIRON CA
  • Differential activation of adrenal steroid receptors in neural and immune tissues of Sprague Dawley, Fischer 344, and Lewis rats.
    J Neuroimmunol Volume: 56 Page(s): 77 - 90
    01/01/1995 Authors: Dhabhar FS; Miller AH; McEwen BS; Spencer RL
  • Natural killer cell activity in major depression: a prospective study of the in vivo effects of desmethylimipramine treatment.
    Eur Neuropsychopharmacol Volume: 5 Suppl Page(s): 83 - 88
    01/01/1995 Authors: Pariante CM; Miller AH
  • Effects of selective type I and II adrenal steroid agonists on immune cell distribution.
    Endocrinology Volume: 135 Page(s): 1934 - 1944
    11/01/1994 Authors: Miller AH; Spencer RL; hassett J; Kim C; Rhee R; Ciurea D; Dhabhar F; McEwen B; Stein M
  • ADRENAL STEROID-MEDIATED REGULATION OF IMMUNE-RESPONSES TO LCMV INFECTION
    FASEB JOURNAL Volume: 8 Page(s): A976 - A976
    03/18/1994 Authors: BIRON CA; MILLER AH; SPENCER RL; LEUNG JJ; THEROUX DM; ORANGE JS; SALAZARMATHER T; SU HC; MCEWEN BS
  • Diurnal and acute stress-induced changes in distribution of peripheral blood leukocyte subpopulations.
    Brain Behav Immun Volume: 8 Page(s): 66 - 79
    03/01/1994 Authors: Dhabhar FS; Miller AH; Stein M; McEwen BS; Spencer RL
  • Lack of association between cortisol hypersecretion and nonsuppression on the DST in patients with Alzheimer's disease.
    Am J Psychiatry Volume: 151 Page(s): 267 - 270
    02/01/1994 Authors: Miller AH; Sastry G; Speranza AJ; Lawlor BA; Mohs RC; Ryan TM; Gabriel SM; Serby M; Schmeidler J; Davis KL
  • Diurnal differences in basal and acute stress levels of type I and type II adrenal steroid receptor activation in neural and immune tissues.
    Endocrinology Volume: 133 Page(s): 1941 - 1950
    11/01/1993 Authors: Spencer RL; Miller AH; Moday H; Stein M; McEwen BS
  • Differential expression of type I adrenal steroid receptors in immune tissues is associated with tissue-specific regulation of type II receptors by aldosterone.
    Endocrinology Volume: 133 Page(s): 2133 - 2140
    11/01/1993 Authors: Miller AH; Spencer RL; Husain A; Rhee R; McEwen BS; Stein M
  • Depression, adrenal steroids, and the immune system.
    Ann Med Volume: 25 Page(s): 481 - 487
    10/01/1993 Authors: Miller AH; Spencer RL; McEwen BS; Stein M
  • CLINICAL AND NEUROENDOCRINE PREDICTORS OF MORTALITY IN ALZHEIMERS-DISEASE
    BIOLOGICAL PSYCHIATRY Volume: 33 Page(s): A140 - A140
    03/15/1993 Authors: SPERANZA A; MOHS R; MILLER A
  • Stress, the hypothalamic-pituitary-adrenal axis, and immune function.
    Adv Exp Med Biol Volume: 335 Page(s): 1 - 5
    01/01/1993 Authors: Stein M; Miller AH
  • Effects of dopamine on T-lymphocyte proliferative responses and serum prolactin concentrations in critically ill patients.
    Crit Care Med Volume: 20 Page(s): 1644 - 1649
    12/01/1992 Authors: Devins SS; Miller A; Herndon BL; O'Toole L; Reisz G
  • Adrenal steroid receptor activation in rat brain and pituitary following dexamethasone: implications for the dexamethasone suppression test.
    Biol Psychiatry Volume: 32 Page(s): 850 - 869
    11/15/1992 Authors: Miller AH; Spencer RL; Pulera M; Kang S; McEwen BS; Stein M
  • Adrenal steroid receptor activation in vivo and immune function.
    Am J Physiol Volume: 261 Page(s): E126 - E131
    07/01/1991 Authors: Miller AH; Spencer RL; Trestman RL; Kim C; McEwen BS; Stein M
  • Biochemical mechanisms of stress-induced impairment of rat T cell mitogenesis.
    J Neuroimmunol Volume: 32 Page(s): 241 - 247
    06/01/1991 Authors: Halper JP; Miller AH; Trestman RL; Santucci AC; Lackner C; Stein M
  • Corticosterone regulation of type I and type II adrenal steroid receptors in brain, pituitary, and immune tissue.
    Brain Res Volume: 549 Page(s): 236 - 246
    05/24/1991 Authors: Spencer RL; Miller AH; Stein M; McEwen BS
  • Depression, natural killer cell activity, and cortisol secretion.
    Biol Psychiatry Volume: 29 Page(s): 878 - 886
    05/01/1991 Authors: Miller AH; Asnis GM; Lackner C; Halbreich U; Norin AJ
  • Depression, the immune system, and health and illness. Findings in search of meaning.
    Arch Gen Psychiatry Volume: 48 Page(s): 171 - 177
    02/01/1991 Authors: Stein M; Miller AH; Trestman RL
  • Adrenal steroid receptor binding in spleen and thymus after stress or dexamethasone.
    Am J Physiol Volume: 259 Page(s): E405 - E412
    09/01/1990 Authors: Miller AH; Spencer RL; Stein M; McEwen BS
  • Plasma dexamethasone and cortisol levels in depressed outpatients.
    J Affect Disord Volume: 16 Page(s): 5 - 10
    01/01/1989 Authors: Asnis GM; Friedman JM; Miller AH; Iqbal N; Lo ES; Cooper TB; Halbreich U; Lemus CZ; van Praag HM; Rubinson E
  • The neuroendocrine response to fenfluramine in depressives and normal controls.
    Biol Psychiatry Volume: 24 Page(s): 117 - 120
    05/01/1988 Authors: Asnis GM; Eisenberg J; van Praag HM; Lemus CZ; Friedman JM; Miller AH
  • Psychoimmunological dysregulation in multiple sclerosis.
    Psychosomatics Volume: 29 Page(s): 398 - 403
    01/01/1988 Authors: Foley FW; Miller AH; Traugott U; LaRocca NG; Scheinberg LC; Bedell JR; Lennox SS
  • THE INVITRO EFFECT OF CORTISOL ON NATURAL-KILLER CELL-ACTIVITY IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER
    PSYCHOPHARMACOLOGY BULLETIN Volume: 23 Page(s): 502 - 504
    01/01/1987 Authors: MILLER AH; ASNIS GM; LACKNER C; NORIN AJ
  • Epstein-Barr virus infection and depression.
    J Clin Psychiatry Volume: 47 Page(s): 529 - 530
    10/01/1986 Authors: Miller AH; Silberstein C; Asnis GM; Munk G; Rubinson E; Spigland I; Norin A
  • Influence of desmethylimipramine on natural killer cell activity.
    Psychiatry Res Volume: 19 Page(s): 9 - 15
    09/01/1986 Authors: Miller AH; Asnis GM; van Praag HM; Norin AJ
  • REVERSIBLE INHIBITION OF NATURAL-KILLER ACTIVITY BY THE TRICYCLIC ANTIDEPRESSANT DESMETHYLIMIPRAMINE
    JOURNAL OF LEUKOCYTE BIOLOGY Volume: 38 Page(s): 184 - 184
    01/01/1985 Authors: MILLER AH; ASNIS GM; VANPRAAG H; NORIN AJ
Read more publications Fewer publications
Directory
  • Faculty Profiles
Emory University Homepage

Contact & Location

Emory University School of Medicine
100 Woodruff Circle
Atlanta, GA  30322 USA
  • Contact Us
  • Maps & Directions
  • Careers

Information For

  • Alumni
  • Faculty & Staff
  • Patients
  • Residents & Fellows
  • Students
Support the School of Medicine School of Medicine Intranet
facebook facebook twitter twitter linkedin linkedin instagram instagram youtube youtube
© 2025 Emory University
  • Privacy Policy
  • Emergency Information
  • EEO Employer-Disability/Veteran Statements